<SEC-DOCUMENT>0001193125-20-250245.txt : 20201026
<SEC-HEADER>0001193125-20-250245.hdr.sgml : 20201026
<ACCEPTANCE-DATETIME>20200921164531
ACCESSION NUMBER:		0001193125-20-250245
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20200916
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200921
DATE AS OF CHANGE:		20200921

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Chewy, Inc.
		CENTRAL INDEX KEY:			0001766502
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-CATALOG & MAIL-ORDER HOUSES [5961]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0202

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38936
		FILM NUMBER:		201186917

	BUSINESS ADDRESS:	
		STREET 1:		1855 GRIFFIN ROAD, SUITE B-42
		CITY:			DANIA BEACH
		STATE:			FL
		ZIP:			33004
		BUSINESS PHONE:		786-320-7111

	MAIL ADDRESS:	
		STREET 1:		1855 GRIFFIN ROAD, SUITE B-42
		CITY:			DANIA BEACH
		STATE:			FL
		ZIP:			33004
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d79628d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:chwy="http://www.chewy.com/20200916" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body>
 <div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2020-09-16_to_2020-09-16">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2020-09-16_to_2020-09-16">0001766502</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="chwy-20200916.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2020-09-16_to_2020-09-16"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001766502</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-09-16</xbrli:startDate> <xbrli:endDate>2020-09-16</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:4.00pt solid #000000">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:3pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2020-09-16_to_2020-09-16">8-K</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">Date of Report (Date of Earliest Event Reported):<ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2020-09-16_to_2020-09-16" format="ixt:datemonthdayyearen"><span style="font-weight:bold"> September</span><span style="font-weight:bold"></span><span style="font-weight:bold"> 16, 2020</span></ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2020-09-16_to_2020-09-16">CHEWY, INC.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">(Exact Name of Registrant as Specified in its Charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2020-09-16_to_2020-09-16" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2020-09-16_to_2020-09-16">001-38936</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2020-09-16_to_2020-09-16">90-1020167</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">Identification No.)</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2020-09-16_to_2020-09-16">1855 Griffin Road</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2020-09-16_to_2020-09-16">Suite B-428</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2020-09-16_to_2020-09-16">Dania Beach</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2020-09-16_to_2020-09-16" format="ixt-sec:stateprovnameen">Florida</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2020-09-16_to_2020-09-16">33004</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">(Address of Principal Executive Offices)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">(Zip Code)</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">Registrant&#8217;s telephone number, including area code: <span style="font-weight:bold"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2020-09-16_to_2020-09-16">(786)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2020-09-16_to_2020-09-16">320-7111</ix:nonNumeric> </span></p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.50pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2020-09-16_to_2020-09-16" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2020-09-16_to_2020-09-16" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2020-09-16_to_2020-09-16" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2020-09-16_to_2020-09-16" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:35%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:31%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">Title of each class</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">Trading Symbol(s)</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange on which</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2020-09-16_to_2020-09-16">Class&#160;A Common Stock, $0.01 Par Value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2020-09-16_to_2020-09-16">CHWY</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2020-09-16_to_2020-09-16" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2020-09-16_to_2020-09-16" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. &#9744;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;8.01. &#160;&#160;Other Events. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Equity Offering </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman;text-align:justify">On September&#160;16, 2020, Chewy, Inc. (the &#8220;<span style="font-weight:bold">Company</span>&#8221;<span style="font-weight:bold"></span>) entered into an Underwriting Agreement (the &#8220;<span style="font-weight:bold">Underwriting Agreement</span>&#8221;), between the Company and Morgan Stanley&#160;&amp; Co. LLC (the &#8220;<span style="font-weight:bold">Underwriter</span>&#8221;), in connection with the Company&#8217;s previously announced underwritten public offering of 5,100,000 shares of Class&#160;A common stock (the &#8220;<span style="font-weight:bold">Offering</span>&#8221;). Pursuant to the Underwriting Agreement, the Company has granted the Underwriter an option to purchase up to an additional 765,000 shares of Class&#160;A common stock. The Underwriting Agreement contains customary representations, warranties, covenants and indemnification obligations of the Company and the Underwriter, as well as termination and other customary provisions. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman;text-align:justify">The Offering was made pursuant to a prospectus supplement, dated September&#160;16, 2020, and filed with the Securities and Exchange Commission (the &#8220;<span style="font-weight:bold">SEC</span>&#8221;), and the base prospectus, dated September&#160;16, 2020, filed as part of the Company&#8217;s automatic shelf registration statement (File <span style="white-space:nowrap">No.&#160;333-248843)</span> that became effective under the Securities Act of 1933, as amended (the &#8220;<span style="font-weight:bold">Securities Act</span>&#8221;) when filed with the SEC on September&#160;16, 2020. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman;text-align:justify">The Offering closed on September&#160;21, 2020. The Company expects to use the net proceeds from the Offering for general corporate purposes, including growth initiatives to expand its total addressable market. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman;text-align:justify">The foregoing summary of the Underwriting Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of such agreement, which is attached as Exhibit 1.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman;text-align:justify">Kirkland and Ellis LLP has issued an opinion, dated September&#160;21, 2020, regarding certain legal matters with respect to the Offering, a copy of which is filed as Exhibit 5.1 hereto. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman;text-align:justify">This Current Report on Form <span style="white-space:nowrap">8-K</span> does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of any securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">(d) Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:9%"></td>

<td style="vertical-align:bottom;width:3%"></td>
<td style="width:86%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit&#160;No.</p> <p style="font-size:6pt; margin-top:0pt; margin-bottom:1pt;text-align:left">&#160;</p></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description of Exhibit</p> <p style="font-size:6pt; margin-top:0pt; margin-bottom:1pt;text-align:left">&#160;</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.1</p></td>
<td style="vertical-align:bottom">&#160;&#160;&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="d79628dex11.htm">Underwriting Agreement, dated September&#160;16, 2020, between Chewy, Inc. and Morgan Stanley&#160;&amp; Co. LLC. </a></p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.1</p></td>
<td style="vertical-align:bottom">&#160;&#160;&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="d79628dex51.htm">Opinion of Kirkland&#160;&amp; Ellis LLP. </a></p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">23.1</p></td>
<td style="vertical-align:bottom">&#160;&#160;&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="d79628dex51.htm">Consent of Kirkland&#160;&amp; Ellis LLP (included in Exhibit 5.1). </a></p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">104</p></td>
<td style="vertical-align:bottom">&#160;&#160;&#160;&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The cover page from this Current Report on Form <span style="white-space:nowrap">8-K,</span> formatted in Inline XBRL.</p></td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:7%; font-size:10pt; font-family:Times New Roman;text-align:justify">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">


<tr>

<td style="width:12%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:87%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CHEWY, INC.</p></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Susan Helfrick</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Susan Helfrick</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General Counsel</p></td></tr>
</table></div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date:&#160;&#160;&#160;&#160;&#160;&#160;September 21, 2020 </p>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d79628dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="right"><B>EXECUTION VERSION </B></P> <P STYLE="margin-top:36pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">CHEWY,
INC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">5,100,000 Shares of Class&nbsp;A Common Stock </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><U>Underwriting Agreement </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="right">September&nbsp;16, 2020 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Morgan
Stanley&nbsp;&amp; Co. LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">1585 Broadway </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">New York, New York
10036 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">Chewy, Inc.,
a Delaware corporation (the &#147;Company&#148;), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the &#147;Underwriters&#148;), for whom you are acting as representatives (the &#147;Representatives&#148;), an
aggregate of 5,100,000 shares of Class&nbsp;A common stock, par value $0.01 per share, of the Company (the &#147;Underwritten Shares&#148;) and, at the option of the Underwriters, up to an additional 765,000 shares of Class&nbsp;A common stock, par
value $0.01 per share, of the Company (the &#147;Option Shares&#148;). The Underwritten Shares and the Option Shares are herein referred to as the &#147;Shares&#148;. The shares of Class&nbsp;A common stock, par value $0.01 per share, and the shares
of Class&nbsp;B common stock, par value $0.01 per share, of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein collectively as the &#147;Stock&#148;. To the extent there are no additional Underwriters
listed on Schedule 1 other than you, the term &#147;Representatives&#148; as used herein shall mean you, as Underwriters, and the terms &#147;Representatives&#148; and &#147;Underwriters&#148; shall mean either the singular or plural as the context
requires. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">The Company hereby confirms its agreement with the several Underwriters concerning the purchase and sale of the Shares, as
follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Registration Statement</U>. The Company has prepared and filed with the
Securities and Exchange Commission (the &#147;Commission&#148;) under the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder (collectively, the &#147;Securities Act&#148;), a registration statement on Form
<FONT STYLE="white-space:nowrap">S-3</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-248843),</FONT> including a base prospectus (the &#147;Base Prospectus&#148;), relating to certain securities of the Company including the Shares. Such
registration statement, as amended at the time it became effective, including the information, if any, deemed pursuant to Rule 430B under the Securities Act to be part of the registration statement at the time of its effectiveness (&#147;Rule 430
Information&#148;), is referred to herein as the &#147;Registration Statement&#148;; and as used herein, the term &#147;Preliminary Prospectus&#148; means the preliminary prospectus supplement relating to the offering of the Shares in the form filed
with the Commission pursuant to Rule 424(b) under the Securities Act and the Base Prospectus, and the term &#147;Prospectus&#148; means the final prospectus supplement to the Base Prospectus and the Base Prospectus in the form first used (or made
available upon request of purchasers pursuant to Rule 173 under the Securities Act) in connection with confirmation of sales of the Shares. Any reference in this underwriting agreement (this &#147;Agreement&#148;)
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
to the Registration Statement, the Preliminary Prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated by reference therein pursuant to Item 12 of Form <FONT
STYLE="white-space:nowrap">S-3</FONT> under the Securities Act, as of the effective date of the Registration Statement or the date of such Preliminary Prospectus or the Prospectus, as the case may be, and any reference to &#147;amend&#148;,
&#147;amendment&#148; or &#147;supplement&#148; with respect to the Registration Statement, the Preliminary Prospectus or the Prospectus shall be deemed to refer to and include any documents on or filed after such date under the Securities Exchange
Act of 1934, as amended, and the rules and regulations of the Commission thereunder (collectively, the &#147;Exchange Act&#148;) that are deemed to be incorporated by reference therein. Capitalized terms used but not defined herein shall have the
meanings given to such terms in the Registration Statement and the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">At or prior to the Applicable Time (as defined below), the
Company had prepared the following information (collectively with the pricing information set forth on Annex A hereto, the &#147;Pricing Disclosure Package&#148;): a Preliminary Prospectus dated September&nbsp;16, 2020 and each &#147;free-writing
prospectus&#148; (as defined pursuant to Rule 405 under the Securities Act) listed on Annex A hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">&#147;Applicable Time&#148; means
4:10 P.M., New York City time, on September&nbsp;16, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Purchase of the
Shares</U>. (a)&nbsp;The Company agrees to issue and sell the Underwritten Shares to the several Underwriters as provided in this Agreement, and each Underwriter, on the basis of the representations, warranties and agreements set forth herein and
subject to the conditions set forth herein, agrees, severally and not jointly, to purchase at a price per share of $54.40 (the &#147;Purchase Price&#148;) from the Company the respective number of Underwritten Shares set forth opposite such
Underwriter&#146;s name in Schedule 1 hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">In addition, the Company agrees to issue and sell the Option Shares to the several
Underwriters as provided in this Agreement, and the Underwriters, on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein, shall have the option to purchase, severally and not
jointly, from the Company the Option Shares at the Purchase Price less an amount per share equal to any dividends or distributions declared by the Company and payable on the Underwritten Shares but not payable on the Option Shares. If any Option
Shares are to be purchased, the number of Option Shares to be purchased by each Underwriter shall be the number of Option Shares which bears the same ratio to the aggregate number of Option Shares being purchased as the number of Underwritten Shares
set forth opposite the name of such Underwriter in Schedule 1 hereto (or such number increased as set forth in Section&nbsp;10 hereof) bears to the aggregate number of Underwritten Shares being purchased from the Company by the several Underwriters,
subject, however, to such adjustments to eliminate any fractional Shares as the Representatives in their sole discretion shall make. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">The
Underwriters may exercise the option to purchase Option Shares at any time in whole, or from time to time in part, on or before the thirtieth day following the date of the Prospectus, by written notice from the Representatives to the Company. Such
notice shall set forth the aggregate number of Option Shares as to which the option is being exercised and the date and time when the Option Shares are to be delivered and paid for, which may be the same date and time as the Closing Date (as
hereinafter defined) but shall not be earlier than the Closing Date nor later than the tenth full business day (as hereinafter </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
defined) after the date of such notice (unless such time and date are postponed in accordance with the provisions of Section&nbsp;10 hereof). Any such notice shall be given at least two business
days prior to the date and time of delivery specified therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company
understands that the Underwriters intend to make a public offering of the Shares, and initially to offer the Shares on the terms set forth in the Pricing Disclosure Package. The Company acknowledges and agrees that the Underwriters may offer and
sell Shares to or through any affiliate of an Underwriter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment for the Shares
shall be made by wire transfer in immediately available funds to the account specified by the Company to the Representatives in the case of the Underwritten Shares, at the offices of Davis Polk&nbsp;&amp; Wardwell LLP at 10:00 A.M., New York City
time, on September&nbsp;21, 2020, or at such other time or place on the same or such other date, not later than the fifth business day thereafter, as the Representatives and the Company may agree upon in writing or, in the case of the Option Shares,
on the date and at the time and place specified by the Representatives in the written notice of the Underwriters&#146; election to purchase such Option Shares. The time and date of such payment for the Underwritten Shares is referred to herein as
the &#147;Closing Date&#148;, and the time and date for such payment for the Option Shares, if other than the Closing Date, is herein referred to as the &#147;Additional Closing Date&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">Payment for the Shares to be purchased on the Closing Date or the Additional Closing Date, as the case may be, shall be made against delivery
to the Representatives for the respective accounts of the several Underwriters of the Shares to be purchased on such date or the Additional Closing Date, as the case may be, with any transfer taxes payable in connection with the sale of such Shares
duly paid by the Company. Delivery of the Shares shall be made through the facilities of The Depository Trust Company (&#147;DTC&#148;) unless the Representatives shall otherwise instruct. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company acknowledges and agrees that the Representatives and the other Underwriters
are acting solely in the capacity of an arm&#146;s length contractual counterparty to the Company with respect to the offering of Shares contemplated hereby (including in connection with determining the terms of the offering) and not as a financial
advisor or a fiduciary to, or an agent of, the Company or any other person. Additionally, neither the Representatives nor any other Underwriter is advising the Company or any other person as to any legal, tax, investment, accounting or regulatory
matters in any jurisdiction. The Company shall consult with its own advisors concerning such matters and shall be responsible for making its own independent investigation and appraisal of the transactions contemplated hereby, and neither the
Representatives nor any other Underwriter shall have any responsibility or liability to the Company with respect thereto. Any review by the Representatives and the other Underwriters of the Company, the transactions contemplated hereby or other
matters relating to such transactions will be performed solely for the benefit of the Representatives and the other Underwriters and shall not be on behalf of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations and Warranties of the
Company</U>. The Company represents and warrants to each Underwriter that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Preliminary Prospectus.</I> No order preventing or suspending the use of the
Preliminary Prospectus has been issued by the Commission, and the Preliminary Prospectus included in the Pricing Disclosure Package, at the time of filing thereof, complied in all material respects with the Securities Act, and the Preliminary
Prospectus did not, at the time of filing thereof, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not
misleading; <U>provided</U> that the Company makes no representation or warranty with respect to any statements or omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by
such Underwriter through the Representatives expressly for use in the Preliminary Prospectus, it being understood and agreed that the only such information furnished by any Underwriter consists of the Underwriter Information (as defined below). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Pricing Disclosure Package</I>. The Pricing Disclosure Package as of the Applicable
Time did not, and as of the Closing Date and as of the Additional Closing Date, as the case may be, will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no representation or warranty with respect to any statements or omissions made in reliance upon and in conformity with information relating
to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in such Pricing Disclosure Package, it being understood and agreed that the only such information furnished by any Underwriter
consists of the Underwriter Information. No statement of material fact included in the Prospectus has been omitted from the Pricing Disclosure Package and no statement of material fact included in the Pricing Disclosure Package that is required to
be included in the Prospectus has been omitted therefrom. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Issuer Free Writing
Prospectus. </I>Other than the Registration Statement, the Preliminary Prospectus and the Prospectus, the Company (including its agents and representatives, other than the Underwriters in their capacity as such) has not prepared, made, used,
authorized, approved or referred to and will not prepare, make, use, authorize, approve or refer to any &#147;written communication&#148; (as defined in Rule 405 under the Securities Act) that constitutes an offer to sell or solicitation of an offer
to buy the Shares (each such communication by the Company or its agents and representatives (other than a communication referred to in clause&nbsp;(i) below) an &#147;Issuer Free Writing Prospectus&#148;) other than (i)&nbsp;any document not
constituting a prospectus pursuant to Section&nbsp;2(a)(10)(a) of the Securities Act or Rule 134 under the Securities Act or (ii)&nbsp;the documents listed on Annex A hereto, each electronic road show and any other written communications approved in
writing in advance by the Representatives. Each such Issuer Free Writing Prospectus complies in all material respects with the Securities Act, has been or will be (within the time period specified in Rule 433) filed in accordance with the Securities
Act (to the extent required thereby) and does not conflict with the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman">
information contained in the Registration Statement or the Pricing Disclosure Package, and, when taken together with the Preliminary Prospectus filed prior to the first use of such Issuer Free
Writing Prospectus, did not, and as of the Closing Date and as of the Additional Closing Date, as the case may be, will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no representation or warranty with respect to any statements or omissions made in each such Issuer Free Writing Prospectus
or Preliminary Prospectus in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in such Issuer Free Writing Prospectus or
Preliminary Prospectus, it being understood and agreed that the only such information furnished by any Underwriter consists of the Underwriter Information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Registration Statement and Prospectus.</I> The Registration Statement is an
&#147;automatic shelf registration statement&#148; as defined under Rule 405 of the Securities Act that has been filed with the Commission not earlier than three years prior to the date hereof; and no notice of objection of the Commission to the use
of such registration statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act has been received by the Company. No order suspending the effectiveness of the Registration Statement has been issued by the
Commission, and no proceeding for that purpose or pursuant to Section&nbsp;8A of the Securities Act against the Company or related to the offering of the Shares has been initiated or, the knowledge of the Company, threatened by the Commission; as of
the applicable effective date of the Registration Statement and any post-effective amendment thereto, the Registration Statement and any such post-effective amendment complied and will comply in all material respects with the Securities Act, and did
not and will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading; and as of the date of the Prospectus and any
amendment or supplement thereto and as of the Closing Date and as of the Additional Closing Date, as the case may be, the Prospectus will comply in all material respects with the Securities Act and will not contain any untrue statement of a material
fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no representation or warranty with respect
to any statements or omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in the Registration Statement
and the Prospectus and any amendment or supplement thereto, it being understood and agreed that the only such information furnished by any Underwriter consists of the Underwriter Information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Incorporated Documents</I>. The documents incorporated by reference in the
Registration Statement, the Prospectus and the Pricing Disclosure Package, when they were filed with the Commission conformed in all material respects to the requirements of the Exchange Act, and none of such documents contained any untrue statement
of a material fact or omitted to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; and any further documents so filed and incorporated by reference in the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman">
Registration Statement, the Prospectus or the Pricing Disclosure Package, when such documents are filed with the Commission, will conform in all material respects to the requirements of the
Exchange Act and will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Financial Statements.</I> The financial statements (including the related notes and
supporting schedules) included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus comply in all material respects with the applicable requirements of the Securities Act and the Exchange Act,
as applicable, and present fairly, in all material respects, the financial condition, results of operations and cash flows of the entities purported to be shown thereby, at the dates and for the periods indicated, and have been prepared in
conformity with generally accepted accounting principles as applied in the United States (&#147;GAAP&#148;) applied on a consistent basis throughout the periods involved, except as otherwise stated therein; the other financial information included
or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus has been derived from the accounting records of the Company and its consolidated subsidiaries and presents fairly the information shown
thereby; and all disclosures included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus regarding <FONT STYLE="white-space:nowrap">&#147;non-GAAP</FONT> financial measures&#148; (as such
term is defined by the rules and regulations of the Commission) comply with Regulation G of the Exchange Act and Item 10 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> of the Securities Act, to the extent applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No Material Adverse Change.</I> Since the date of the latest audited financial
statements of the Company included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus, (i)&nbsp;there has not been any change in the capital stock, short-term debt or long-term debt of the
Company or any of its subsidiaries, or any dividend or distribution of any kind declared, set aside for payment, paid or made by the Company on any class of capital stock, (ii)&nbsp;there has not been any material adverse change or any development
that would reasonably be expected to result in a prospective material adverse change, in the condition (financial or otherwise), results of operations or business of the Company and its subsidiaries, taken as a whole, (iii)&nbsp;neither the Company
nor any of its subsidiaries has entered into any transaction or agreement (whether or not in the ordinary course of business) that is material to the Company and its subsidiaries taken as a whole or incurred any liability or obligation, direct or
contingent, that is material to the Company and its subsidiaries taken as a whole; and (iv)&nbsp;neither the Company nor any of its subsidiaries has sustained any loss or interference with its business that is material to the Company and its
subsidiaries taken as a whole and that is either from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor disturbance or dispute or any action, order or decree of any court or arbitrator or governmental
or regulatory authority, except in each case as set forth or contemplated in the Registration Statement, the Pricing Disclosure Package and the Prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Organization and Good
Standing.</I> Each of the Company and its subsidiaries has been duly organized, is validly existing and, to the extent such concept is applicable, in good standing as a corporation, partnership or limited liability company, as the case may be, under
the laws of its jurisdiction of organization and is duly qualified to do business and, to the extent such concept is applicable, in good standing as a foreign corporation or other business entity in each jurisdiction in which its ownership or lease
of property or the conduct of its businesses requires such qualification, except where the failure to be so qualified or in good standing would not, individually or in the aggregate, reasonably be expected to have a material adverse effect on the
condition (financial or otherwise), results of operations, business, properties or assets of the Company and its subsidiaries, taken as a whole or on the performance by the Company of its obligations under this Agreement (a &#147;Material Adverse
Effect&#148;). Each of the Company and its subsidiaries has all requisite corporate and other organizational power and authority necessary to own or hold its properties and to conduct its businesses as described in the Registration Statement, the
Pricing Disclosure Package and the Prospectus, except as would not reasonably be expected to have a Material Adverse Effect. As of the Closing Date, the Company will not have any subsidiaries other than the subsidiaries listed in Exhibit 21.1 to the
Registration Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Capitalization.</I> The Company and its subsidiaries on
a consolidated basis had, as of the date indicated in the Registration Statement, the Pricing Disclosure Package and the Prospectus, and will have as of the Closing Date, the issued and outstanding capitalization as set forth in each of the Pricing
Disclosure Package and the Prospectus under the caption &#147;Capitalization&#148; after giving effect to adjustments set forth thereunder; the capital stock of the Company conforms in all material respects to the description thereof contained in
the Registration Statement, the Pricing Disclosure Package and the Prospectus. All of the issued shares of capital stock of the Company have been duly authorized and validly issued and are fully paid and
<FONT STYLE="white-space:nowrap">non-assessable</FONT> and are not subject to any <FONT STYLE="white-space:nowrap">pre-emptive</FONT> or similar rights; there are no outstanding rights (including, without limitation,
<FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights), warrants or options to acquire, or instruments convertible into or exchangeable for, any shares of capital stock or other equity interest in the Company or any of its subsidiaries, or any
contract, commitment, agreement, understanding or arrangement of any kind relating to the issuance of any capital stock of the Company or any such subsidiary, any such convertible or exchangeable securities or any such rights, warrants or options.
All of the issued shares of capital stock or other ownership interest of each subsidiary of the Company have been duly authorized and validly issued and, in the case of capital stock, are fully paid and
<FONT STYLE="white-space:nowrap">non-assessable</FONT> and all such shares or other ownership interests owned directly or indirectly by the Company are free and clear of all liens, encumbrances, equities or claims, except for such liens,
encumbrances, equities or claims as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Stock Options</I>. The Company has not granted any, and there are no outstanding,
stock options. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Underwriting Agreement. </I>The
Company has all requisite corporate power and authority to execute, deliver and perform its obligations under this Agreement and this Agreement has been duly authorized, executed and delivered by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>The Shares. </I>The Shares to be issued and sold by the Company hereunder have been
duly authorized by the Company and, when issued and delivered and paid for as provided herein, will be duly and validly issued, will be fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> and will conform to the descriptions
thereof in the Registration Statement, the Pricing Disclosure Package and the Prospectus; and the issuance of the Shares is not subject to any preemptive or similar rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No Violation or Default.</I> Neither the Company nor any of its subsidiaries is
(i)&nbsp;in violation of its charter or <FONT STYLE="white-space:nowrap">by-laws</FONT> or similar organizational documents; (ii)&nbsp;in default, and no event has occurred that, with notice or lapse of time or both, would constitute such a default,
in the due performance or observance of any term, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the
Company or any of its subsidiaries is bound or to which any property or asset of the Company or any of its subsidiaries is subject; or (iii)&nbsp;in violation of any law or statute or any judgment, order, rule or regulation of any court or
arbitrator or governmental or regulatory authority, except, in the case of clauses (ii)&nbsp;and (iii) above, for any such default or violation that would not, individually or in the aggregate, have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No Conflicts. </I>The offer, issuance and sale of the Shares, the execution,
delivery and performance by the Company and each subsidiary of the Company, to the extent a party thereto, of this Agreement, as applicable, and the consummation of the transactions contemplated hereby, thereby and by the Registration Statement, the
Pricing Disclosure Package and the Prospectus, will not (i)&nbsp;conflict with or result in a breach or violation of any of the terms or provisions of, impose any lien, charge or encumbrance upon any property or assets of the Company or its
subsidiaries, or constitute a default under, result in the termination, modification or acceleration of, any indenture, mortgage, deed of trust, loan agreement, license, lease or other agreement or instrument to which the Company or any of its
subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any of the property or assets of the Company or any of its subsidiaries is subject, (ii)&nbsp;result in any violation of the provisions of the charter or
<FONT STYLE="white-space:nowrap">by-laws</FONT> (or similar organizational documents) of the Company or any of its subsidiaries or (iii)&nbsp;result in any violation of any law or statute or any judgment, order, decree, rule or regulation of any
court or governmental agency or body having jurisdiction over the Company or any of its subsidiaries or any of their properties or assets, except, with respect to clauses (i)&nbsp;and (iii), as would not reasonably be expected to have a Material
Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No Consents Required.</I> No consent, approval, authorization
or order of, or filing, registration or qualification with any U.S. court or governmental agency or body, or to the knowledge of the Company, any <FONT STYLE="white-space:nowrap">non-U.S.</FONT> court or governmental agency or body, having
jurisdiction over the Company or any of its subsidiaries or any of their </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman">
properties or assets is required for the offer, issuance and sale of the Shares and the execution, delivery and performance by the Company of this Agreement, except for (i)&nbsp;the registration
of the Shares under the Securities Act and such consents, approvals, authorizations, orders, filings, registrations or qualifications as may be required by the Financial Industry Regulatory Authority, Inc. (&#147;FINRA&#148;) and under applicable
state securities or Blue Sky laws in connection with the purchase and distribution of the Shares by the Underwriters, (ii)&nbsp;as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus or (iii)&nbsp;any such
consents, approvals, authorizations, orders, filings, registrations or qualifications the failure of which to obtain would not, individually or in the aggregate, have a Material Adverse Effect or materially affect the ability to consummate the
transactions contemplated by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(p)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Legal Proceedings.</I> Except as
set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus, there are no legal, governmental or regulatory investigations, actions, demands, claims, suits, arbitrations, inquiries or proceedings (&#147;Actions&#148;)
pending to which the Company or any of its subsidiaries is a party or of which any property or assets of the Company or any of its subsidiaries is the subject that would, in the aggregate, reasonably be expected to have a Material Adverse Effect or
would, in the aggregate, reasonably be expected to have a material adverse effect on the performance by the Company of its obligations under this Agreement or the consummation of any of the transactions contemplated hereby, thereby or by the
Registration Statement, the Pricing Disclosure Package and the Prospectus. Except as set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus, to the knowledge of the Company, no such Actions are threatened by
governmental authorities or others; and (i)&nbsp;there are no current or pending Actions that are required under the Securities Act to be described in the Registration Statement, the Pricing Disclosure Package or the Prospectus that are not so
described in the Registration Statement, the Pricing Disclosure Package, the Prospectus or in any of the documents incorporated by reference therein, and (ii)&nbsp;there are no statutes, regulations, or contracts or other documents that are required
under the Securities Act to be filed as exhibits to the Registration Statement or described in the Registration Statement, the Pricing Disclosure Package or the Prospectus that are not so filed as exhibits to the Registration Statement or described
in the Registration Statement, the Pricing Disclosure Package, the Prospectus or in any of the documents incorporated by reference therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(q)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Independent Accountants</I>. Deloitte&nbsp;&amp; Touche LLP, who have certified
certain financial statements of the Company and its subsidiaries, whose report appears or is incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus and who have delivered an initial letter referred
to in Section&nbsp;6(e) hereof, are independent registered public accountants with respect to the Company and its subsidiaries within the meaning of the Securities Act and the rules and regulations adopted by the Commission and the Public Company
Accounting Oversight Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(r)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Title to Real and Personal Property.</I> Each of
the Company and its subsidiaries has good and marketable title to all the properties and assets reflected as owned in the financial statements referred to in Section&nbsp;3(f) hereof, in each case free and clear of any security interests, mortgages,
liens, encumbrances, equities, claims and other </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman">
defects, except for such liens, encumbrances, equities, claims or defects (i)&nbsp;as do not materially interfere with the current use made or proposed in the Pricing Disclosure Package and the
Prospectus to be made of such property by the Company and its subsidiaries or (ii)&nbsp;as would not reasonably be expected to have a Material Adverse Effect. Except as would not result in a Material Adverse Effect, the real property, improvements,
equipment and personal property held under lease by the Company and its subsidiaries are held under valid and enforceable leases, with such exceptions as are not material and do not materially interfere with the use made or proposed to be made of
such real property, improvements, equipment or personal property by the Company and its subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(s)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Intellectual Property.</I> Except as would not reasonably be expected, individually
or in the aggregate, to have a Material Adverse Effect, each of the Company and its subsidiaries owns or otherwise possesses adequate rights (collectively, the &#147;Intellectual Property Rights&#148;) to use all material patents, patent
applications, trademarks, service marks, trade names, domain names, copyrights and registrations and applications thereof, licenses, <FONT STYLE="white-space:nowrap">know-how,</FONT> software, systems and technology (including trade secrets and
other unpatented and/or unpatentable proprietary or confidential information or systems) and other intellectual property reasonably necessary for the conduct of their respective businesses. The Company and its subsidiaries have not received any
notice of infringement of, or conflict with, asserted Intellectual Property Rights of others, which infringement or conflict, if the subject of an unfavorable decision, would reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(t)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No Undisclosed Relationships.</I> No relationship, direct or indirect, exists
between or among the Company or any of its subsidiaries, on the one hand, and the directors, officers, stockholders, customers, suppliers or other affiliates of the Company or any of its subsidiaries, on the other, that is required by the Securities
Act to be described in each of the Registration Statement and the Prospectus and that is not so described in such documents and in the Pricing Disclosure Package. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(u)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Investment Company Act.</I> The Company is not, and after giving effect to the
offering and sale of the Shares and the application of the proceeds thereof as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, will not be, required to register as an &#147;investment company&#148; within
the meaning of the Investment Company Act of 1940, as amended and the rules and regulations of the Commission thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Taxes</I>. Except, in each case, as would not have a Material Adverse Effect, the
Company and each of its subsidiaries have filed all federal, state, local and <FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax returns required to be filed by them through the date hereof, subject to permitted extensions, and have paid all taxes
due and payable by them (other than taxes that are being contested in good faith and for which adequate reserves have been provided in accordance with GAAP), and no tax deficiency has been determined adversely to the Company or any of its
subsidiaries, nor does the Company have any knowledge of any tax deficiencies that have been, or could reasonably be expected to be, asserted against the Company or any of its subsidiaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(w)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Accuracy of Statements</I>. The
statements set forth in the Pricing Disclosure Package and the Prospectus under the caption &#147;Description of Common Stock,&#148; insofar as they purport to constitute a summary of the terms of the Stock, and under the caption &#147;Material U.S.
Federal Income Tax Consequences for <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders,&#148; insofar as they purport to describe the provisions of the United States federal tax laws, fairly and accurately summarize in all material respects
the matters described therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Licenses and Permits.</I> Each of the Company
and its subsidiaries has such permits, licenses, approvals, consents, franchises, certificates of need and other approvals or authorizations of governmental or regulatory authorities (&#147;Permits&#148;) as are necessary under applicable law to
conduct its respective businesses in the manner described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, except for any of the foregoing that would not, in the aggregate, reasonably be expected to have a Material
Adverse Effect. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, none of the Company or any of its subsidiaries has received notice of any proceedings related to the revocation or modification of
any such Permits that, individually or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would reasonably be expected to have a Material Adverse Effect or has any reason to believe that any such Permits will not be
renewed in the ordinary course. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(y)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No Labor Disputes.</I> No labor disturbance by
or dispute with the employees of the Company or any of its subsidiaries exists or, to the knowledge of the Company, is imminent that could reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(z)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Certain Environmental Matters</I>. (i)&nbsp;There are no proceedings that are
pending, or to the knowledge of the Company, threatened, against the Company or any of its subsidiaries under any laws, regulations, ordinances, rules, orders, judgments, decrees, permits or other legal requirements of any governmental authority,
including without limitation any international, foreign, national, state, provincial, regional, or local authority, relating to pollution, the protection of human health or safety (to the extent related to exposure to hazardous or toxic substances),
the environment, or natural resources, including with respect to the use, handling, storage, manufacturing, transportation, treatment, discharge, disposal or release of hazardous or toxic substances or wastes, pollutants or contaminants
(&#147;Environmental Laws&#148;) in which a governmental authority is also a party, other than such proceedings regarding which it is reasonably believed no monetary sanctions of $100,000 or more will be imposed, (ii)&nbsp;to the knowledge of the
Company, there are no issues regarding compliance with Environmental Laws, including any pending or proposed Environmental Laws, or liabilities or other obligations under Environmental Laws or concerning hazardous or toxic substances or wastes,
pollutants or contaminants and (iii)&nbsp;none of the Company or any of its subsidiaries anticipates capital expenditures relating to Environmental Laws, in the case of each of clause (ii)&nbsp;and (iii) above, that would reasonably be expected to
have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(aa)&nbsp;&nbsp;&nbsp;&nbsp;<I>Compliance with ERISA</I>. (i)&nbsp;Each
employee benefit plan, within the meaning of Section&nbsp;3(3) of the Employee Retirement Income Security Act of 1974, as amended (&#147;ERISA&#148;), for which the Company or any member of its &#147;Controlled Group&#148; (defined as any
organization which is a member of a controlled group of corporations within the meaning of Section&nbsp;414 (b) or (c)&nbsp;of the Internal Revenue Code of 1986, as amended (the &#147;Code&#148;), and for the purpose of Section&nbsp;302 of ERISA
and/or Section&nbsp;412, 4971, 4977, 4980D, 4980E and/or each &#147;applicable section&#148; under Section&nbsp;414(t)(2) of the Code, with the meaning of Section&nbsp;414(b), (c), (m) or (o)&nbsp;of the Code) would have any liability (each, a
&#147;Plan&#148;) has been maintained in compliance with its terms and the requirements of any applicable statutes, orders, rules and regulations, including but not limited to, ERISA and the Code, except for noncompliance that would not,
individually or in the aggregate, have a Material Adverse Effect; (ii)&nbsp;no prohibited transaction, within the meaning of Section&nbsp;406 of ERISA or Section&nbsp;4975 of the Code, has occurred with respect to any Plan excluding transactions
effected pursuant to a statutory or administrative exemption that would not, individually or in the aggregate, have a Material Adverse Effect; (iii)&nbsp;for each Plan that is subject to the funding rules of Section&nbsp;412 of the Code or
Section&nbsp;302 of ERISA, the minimum funding standard of Section&nbsp;412 of the Code or Section&nbsp;302 of ERISA, as applicable, has been satisfied (without taking into account any waiver thereof or extension of any amortization period) and is
reasonably expected to be satisfied in the future (without taking into account any waiver thereof or extension of any amortization period), except as would not, individually or in the aggregate, have a Material Adverse Effect; (iv)&nbsp;no
&#147;reportable event&#148; (within the meaning of Section&nbsp;4043(c) of ERISA) has occurred or is reasonably expected to occur that either has had, or would, individually or in the aggregate, reasonably be expected to have, a Material Adverse
Effect; (v)&nbsp;neither the Company nor any member of the Controlled Group has incurred, nor reasonably expects to incur, any liability under Title IV of ERISA (other than contributions to the Plan or premiums to the Pension Benefit Guaranty
Corporation (&#147;PBGC&#148;), in the ordinary course and without default) in respect of a Plan (including a &#147;multiemployer plan&#148;, within the meaning of Section&nbsp;4001(a)(3) of ERISA) that would have a Material Adverse Effect;
(vi)&nbsp;to the Company&#146;s knowledge, there is no pending audit or investigation by the Internal Revenue Service, the U.S. Department of Labor, the Pension Benefit Guaranty Corporation or any other governmental agency or any foreign regulatory
agency with respect to any Plan that would, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; and (vii)&nbsp;none of the following events has occurred or is reasonably likely to occur, except as would not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, (x)&nbsp;a material increase in the aggregate amount of contributions required to be made to all Plans by the Company or its subsidiaries in the current
fiscal year of the Company and its subsidiaries compared to the amount of such contributions made in the Company and its subsidiaries&#146; most recently completed fiscal year, other than an increase in contributions due solely to ordinary course
hiring which results in an increase in the number of Company employees participating in Plans; or (y)&nbsp;a material increase in the Company and its subsidiaries&#146; &#147;accumulated post-retirement benefit obligations&#148; (within the meaning
of Statement of Financial Accounting Standards 106) compared to the amount of such obligations in the Company and its subsidiaries&#146; most recently completed fiscal year. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(bb)&nbsp;&nbsp;&nbsp;&nbsp;<I>Disclosure Controls</I>. Each of the Company
and its subsidiaries maintain an effective system of &#147;disclosure controls and procedures&#148; (as defined in Rule <FONT STYLE="white-space:nowrap">13a-15(e)</FONT> of the Exchange Act) that complies with the requirements of the Exchange Act
and that has been designed to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the
Commission&#146;s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company&#146;s management as appropriate to allow timely decisions regarding required disclosure.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(cc)&nbsp;&nbsp;&nbsp;&nbsp;<I>Accounting Controls.</I> Each of the Company and its subsidiaries maintains a system of
internal control over financial reporting (as defined in Rule <FONT STYLE="white-space:nowrap">13a-15(f)</FONT> of the Exchange Act) that comply with the requirements of the Exchange Act and have been designed by, or under the supervision of, their
respective principal executive and principal financial officers, or persons performing similar functions, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with GAAP. The Company and its subsidiaries maintain internal accounting controls sufficient to provide reasonable assurances that (i)&nbsp;transactions are executed in accordance with management&#146;s general or specific
authorization, (ii)&nbsp;transactions are recorded as necessary to permit preparation of the Company&#146;s financial statements in conformity with GAAP and to maintain accountability for its assets, (iii)&nbsp;access to the Company&#146;s assets is
permitted only in accordance with management&#146;s general or specific authorization and (iv)&nbsp;the recorded accountability for the Company&#146;s assets is compared with existing assets at reasonable intervals and appropriate action is taken
with respect to any differences and (v)&nbsp;interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement, the Prospectus and the Pricing Disclosure Package fairly presents the
information called for in all material respects and is prepared in accordance with the Commission&#146;s rules and guidelines applicable thereto. Since the end of the Company&#146;s most recent audited fiscal year, there has been (i)&nbsp;no
material weakness in the Company&#146;s internal control over financial reporting (whether or not remediated) and (ii)&nbsp;no change in the Company&#146;s internal control over financial reporting that has materially affected, or is reasonably
likely to materially affect, the Company&#146;s internal control over financial reporting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(dd)&nbsp;&nbsp;&nbsp;&nbsp;<I>Insurance. </I>The Company and its subsidiaries, taken as a whole, are insured against such
losses and risks and in such amounts as the Company reasonably believes are adequate to protect the Company and its subsidiaries and their respective businesses; and neither the Company nor any of its subsidiaries has (i)&nbsp;received notice from
any insurer or agent of such insurer that capital improvements or other expenditures are required or necessary to be made in order to continue such insurance or (ii)&nbsp;any reason to believe that it will not be able to renew its existing insurance
coverage as and when such coverage expires or to obtain similar coverage at reasonable cost from similar insurers as may be necessary to continue its business in all material respects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(ee)&nbsp;&nbsp;&nbsp;&nbsp;<I>Cybersecurity; Data Protection</I>. (i)(x) To the Company&#146;s knowledge, there has been no
security breach, violation, outage, unauthorized access or use, or other compromise of, or relating to, any of the Company&#146;s or any of its </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman">
subsidiaries&#146; information technology and computer systems, networks, hardware, software, data (including the data of their respective customers, employees, suppliers, vendors and any third
party data maintained by or on behalf of them), equipment or technology (collectively, &#147;IT Systems and Data&#148;) which could have a Material Adverse Effect and (y)&nbsp;the Company and its subsidiaries have not been notified of, and have no
knowledge of any event or condition that would reasonably be expected to result in, any security breach or other compromise to their IT Systems and Data, except of any event or condition that would not reasonably be expected to have a Material
Adverse Effect; (ii)&nbsp;except as would not reasonably be expected to have a Material Adverse Effect, the Company and its subsidiaries have implemented and maintained commercially reasonable controls, policies, procedures and safeguards to
maintain and protect their material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and Data used in connection with their businesses; and (iii)&nbsp;the Company and its subsidiaries are
presently in compliance with all applicable laws and statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations, in each case, relating
to the privacy and security of the IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not, in the case of this clause (iii), individually or in the
aggregate, have a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(ff)&nbsp;&nbsp;&nbsp;&nbsp;<I>No Unlawful Payments.</I> None of the Company
or any of its subsidiaries or any of their respective directors or officers, nor, to the knowledge of the Company, any agent, employee, affiliate or other person associated with or acting on behalf of the Company or any of its subsidiaries, has
(i)&nbsp;used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense relating to political activity; (ii)&nbsp;made or taken an act in furtherance of an offer, promise or authorization of any direct or
indirect unlawful payment or benefit to any foreign or domestic government official or employee, including of any government-owned or controlled entity or of a public international organization, or any person acting in an official capacity for or on
behalf of any of the foregoing, or any political party or party official or candidate for political office; (iii)&nbsp;violated or is in violation of any provision of the Foreign Corrupt Practices Act of 1977, as amended, or any applicable law or
regulation implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, or committed an offence under the Bribery Act 2010 of the United Kingdom or any other applicable anti-bribery or
anti-corruption law; or (iv)&nbsp;made, offered, agreed, requested or taken an act in furtherance of any unlawful bribe or other unlawful benefit, including, without limitation, any rebate, payoff, influence payment, kickback or other unlawful or
improper payment or benefit. The Company and its subsidiaries have instituted, maintain and enforce, and will continue to maintain and enforce policies and procedures designed to promote and ensure compliance with all applicable anti-bribery and
anti-corruption laws. Neither the Company nor its subsidiaries will use, directly or indirectly, the proceeds of the offering of the Shares in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or
anything else of value, to any person in violation of any applicable anti-corruption laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(gg)&nbsp;&nbsp;&nbsp;&nbsp;<I>Compliance with Anti-Money Laundering
Laws</I>. The operations of the Company and its subsidiaries are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as
amended, the money laundering statutes of all jurisdictions, the rules and regulations thereunder and any related or similar applicable rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the
&#147;Money Laundering Laws&#148;) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or its subsidiaries with respect to the Money Laundering Laws is pending
or, to the knowledge of the Company, threatened. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(hh)&nbsp;&nbsp;&nbsp;&nbsp;<I>No Conflicts with Sanctions Laws.
</I>None of the Company or any of its subsidiaries or any of their respective directors or officers nor, to the knowledge of the Company, any agent, employee, affiliate or other person associated with or acting on behalf of the Company or any of its
subsidiaries is, or, to the best knowledge of the Company, is controlled by an individual or entity that is, currently the subject or the target of any sanctions administered or enforced by the U.S. government (including, without limitation, the
Office of Foreign Assets Control of the U.S. Department of the Treasury (&#147;OFAC&#148;) or the U.S. Department of State and including, without limitation, the designation as a &#147;specially designated national&#148; or &#147;blocked
person&#148;), the United Nations Security Council (&#147;UNSC&#148;), the European Union, Her Majesty&#146;s Treasury (&#147;HMT&#148;) or other relevant sanctions authority (collectively, &#147;Sanctions&#148;), nor is the Company or any of its
subsidiaries located, organized or resident in a country or territory that is the subject or target of Sanctions, including, without limitation, Crimea, Cuba, Iran, North Korea and Syria (each, a &#147;Sanctioned Country&#148;); and the Company will
not directly or indirectly use the proceeds of the offering of the Shares hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity (i)&nbsp;to fund or facilitate any
activities of or business with any person that, at the time of such funding or facilitation, is the subject or target of Sanctions, (ii)&nbsp;to fund or facilitate any activities of or business in any Sanctioned Country or (iii)&nbsp;in any other
manner that will result in a violation by any person (including any person participating in the transaction, whether as underwriter, advisor, investor or otherwise) of Sanctions. For the past five years, the Company and its subsidiaries have not
knowingly engaged in and are not now knowingly engaged in any dealings or transactions with any person that at the time of the dealing or transaction is or was the subject or the target of Sanctions or with any Sanctioned Country. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;<I>No Restrictions on Subsidiaries</I>. Except as may be limited by applicable state corporation
law or comparable laws or as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, no subsidiary of the Company will, as of the Closing Date, be prohibited, directly or indirectly, from paying any dividends to
the Company, from making any other distribution on such subsidiary&#146;s capital stock or other ownership interests, from repaying to the Company any loans or advances to such subsidiary from the Company, or from transferring any of such
subsidiary&#146;s property or assets to the Company or any other subsidiary of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(jj)&nbsp;&nbsp;&nbsp;&nbsp;<I>No Broker&#146;s Fees.</I> None of the
Company or any of its subsidiaries is a party to any contract, agreement or understanding with any person (other than this Agreement) that could give rise to a valid claim against any of them or the Underwriters for a brokerage commission,
finder&#146;s fee or like payment in connection with the offering and sale of the Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(kk)&nbsp;&nbsp;&nbsp;&nbsp;<I>No Registration Rights</I>. No person has the right to require the Company or any of its
subsidiaries to register any securities for sale under the Securities Act by reason of the filing of the Registration Statement with the Commission or the offer, issuance and sale of the Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(ll)&nbsp;&nbsp;&nbsp;&nbsp;<I>No Stabilization</I>. Neither the Company nor any of its subsidiaries has taken or will take,
directly or indirectly, any action designed to or that could reasonably be expected to cause or result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(mm)&nbsp;&nbsp;&nbsp;&nbsp;<I>Margin Rules</I>. None of the transactions contemplated by this Agreement (including, without
limitation, the use of the proceeds from the sale of the Shares), the Registration Statement, the Pricing Disclosure Package or the Prospectus will violate or result in a violation of Regulations T, U or X of the Board of Governors of the Federal
Reserve System. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(nn)&nbsp;&nbsp;&nbsp;&nbsp;<I>Forward-Looking Statements</I>. No forward-looking statement (within the
meaning of Section&nbsp;27A of the Securities Act and Section&nbsp;21E of the Exchange Act) included or incorporated by reference in any of the Registration Statement, the Pricing Disclosure Package or the Prospectus has been made or reaffirmed
without a reasonable basis or has been disclosed other than in good faith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(oo)&nbsp;&nbsp;&nbsp;&nbsp;<I>Statistical and
Market Data</I>. Any third-party statistical and market-related data included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus are based on or derived from sources that the Company
believes to be reliable and accurate in all material respects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(pp)&nbsp;&nbsp;&nbsp;&nbsp;<I>Sarbanes-Oxley Act</I>.
There is and has been no failure on the part of the Company or any of the Company&#146;s directors or officers, in their capacities as such, to comply with any applicable provision of the Sarbanes-Oxley Act of 2002, as amended and the rules and
regulations promulgated in connection therewith, including Section&nbsp;402 related to loans and Sections 302 and 906 related to certifications, to the extent compliance is required as of the date of the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(qq)&nbsp;&nbsp;&nbsp;&nbsp;<I>Status Under the Securities Act</I>. At the time of filing the Registration Statement and any
post-effective amendment thereto, at the earliest time thereafter that the Company or any offering participant made a <I>bona fide</I> offer (within the meaning of Rule 164(h)(2) under the Securities Act) of the Shares and at the date hereof, the
Company was not and is not an &#147;ineligible issuer,&#148; and is a well-known seasoned issuer, in each case as defined in Rule 405 under the Securities Act. The Company has paid the registration fee for this offering pursuant to Rule 456(b)(1)
under the Securities Act or will pay such fee within the time period required by such rule (without giving effect to the proviso </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman">
therein) and in any event prior to the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(rr)&nbsp;&nbsp;&nbsp;&nbsp;<I>No Ratings</I>. There are (and prior to the Closing Date, will be) no debt securities,
convertible securities or preferred stock issued or guaranteed by the Company or any of its subsidiaries that are rated by a &#147;nationally recognized statistical rating organization&#148;, as such term is defined in Section&nbsp;3(a)(62) under
the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">Any certificate signed by any officer of the Company and delivered to the Representatives or counsel
for the Underwriters in connection with the offering of the Shares shall be deemed a representation and warranty by such party, as to matters covered thereby, to each Underwriter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Further Agreements of the Company</U>. The Company covenants and agrees with each
Underwriter that: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Required Filings.</I> The Company will file the final
Prospectus with the Commission within the time periods specified by Rule 424(b) and 430B under the Securities Act, will file any Issuer Free Writing Prospectus to the extent required by Rule 433 under the Securities Act; the Company will file
promptly all reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of the Prospectus and for
so long as the delivery of a prospectus is required in connection with the offering or sale of the Shares; and the Company will furnish copies of the Prospectus and each Issuer Free Writing Prospectus (to the extent not previously delivered) to the
Underwriters in New York City prior to 10:00 A.M., New York City time, on the business day next succeeding the date of this Agreement in such quantities as the Representatives may reasonably request. The Company will pay the registration fee for
this offering within the time period required by Rule 456(b)(1) under the Securities Act (without giving effect to the proviso therein) and in any event prior to the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Delivery of Copies.</I> The Company will deliver, without charge, (i)&nbsp;to the
Representatives, three copies of the Registration Statement as originally filed and each amendment thereto, in each case including all exhibits and consents filed therewith; and (ii)&nbsp;to each Underwriter (A)&nbsp;a conformed copy of the
Registration Statement as originally filed and each amendment thereto (without exhibits) and (B)&nbsp;during the Prospectus Delivery Period (as defined below), as many copies of the Prospectus (including all amendments and supplements thereto and
each Issuer Free Writing Prospectus) as the Representatives may reasonably request. As used herein, the term &#147;Prospectus Delivery Period&#148; means such period of time after the first date of the public offering of the Shares as in the opinion
of counsel for the Underwriters a prospectus relating to the Shares is required by law to be delivered (or required to be delivered but for Rule 172 under the Securities Act) in connection with sales of the Shares by any Underwriter or dealer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Amendments or Supplements, Issuer Free Writing Prospectuses.</I> Before using,
authorizing, approving, referring to or filing any Issuer Free Writing Prospectus, and before filing any amendment or supplement to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman">
Registration Statement, the Pricing Disclosure Package or the Prospectus, whether before or after the time that the Registration Statement becomes effective, the Company will furnish to the
Representatives and counsel for the Underwriters a copy of the proposed Issuer Free Writing Prospectus, amendment or supplement for review and will not use, authorize, approve, refer to or file any such Issuer Free Writing Prospectus or file any
such proposed amendment or supplement to which the Representatives reasonably object. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Notice to the Representatives.</I> The Company will advise the Representatives
promptly, and confirm such advice in writing (which may be by electronic mail), (i) when the Registration Statement has become effective; (ii)&nbsp;when any amendment to the Registration Statement has been filed or becomes effective; (iii)&nbsp;when
any supplement to the Pricing Disclosure Package, the Prospectus or any Issuer Free Writing Prospectus or any amendment to the Prospectus has been filed or distributed; (iv)&nbsp;of any request by the Commission for any amendment to the Registration
Statement or any amendment or supplement to the Prospectus or the receipt of any comments from the Commission relating to the Registration Statement or any other request by the Commission for any additional information; (v)&nbsp;of the issuance by
the Commission of any order suspending the effectiveness of the Registration Statement or preventing or suspending the use of the Preliminary Prospectus, any of the Pricing Disclosure Package or the Prospectus or the initiation or threatening of any
proceeding for that purpose or pursuant to Section&nbsp;8A of the Securities Act; (vi)&nbsp;of the occurrence of any event or development within the Prospectus Delivery Period as a result of which the Prospectus, any of the Pricing Disclosure
Package or any Issuer Free Writing Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances
existing when the Prospectus, the Pricing Disclosure Package or any such Issuer Free Writing Prospectus is delivered to a purchaser, not misleading; (vii)&nbsp;of the receipt by the Company of any notice of objection of the Commission to the use of
the Registration Statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act; and (viii)&nbsp;of the receipt by the Company of any notice with respect to any suspension of the qualification of the Shares for
offer and sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and the Company will use its commercially reasonable efforts to prevent the issuance of any such order suspending the effectiveness of the
Registration Statement, preventing or suspending the use of the Preliminary Prospectus, any of the Pricing Disclosure Package or the Prospectus or suspending any such qualification of the Shares and, if any such order is issued, will use its
reasonable best efforts to obtain as soon as possible the withdrawal thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Ongoing Compliance.</I> (1)&nbsp;If during the Prospectus Delivery Period
(i)&nbsp;any event or development shall occur or condition shall exist as a result of which the Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact necessary in order to
make the statements therein, in the light of the circumstances existing when the Prospectus is delivered to a purchaser, not misleading or (ii)&nbsp;it is necessary to amend or supplement the Prospectus to comply with law, the Company will promptly
notify the Underwriters thereof and forthwith prepare and, subject to paragraph&nbsp;(c) above, file with the Commission and furnish to the Underwriters and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman">
to such dealers as the Representatives may designate such amendments or supplements to the Prospectus (or any document to be filed with the Commission and incorporated by reference therein) as
may be necessary so that the statements in the Prospectus as so amended or supplemented (or any document to be filed with the Commission and incorporated by reference therein) will not, in the light of the circumstances existing when the Prospectus
is delivered to a purchaser, be misleading or so that the Prospectus will comply with law and (2)&nbsp;if at any time prior to the Closing Date (i)&nbsp;any event or development shall occur or condition shall exist as a result of which the Pricing
Disclosure Package as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances existing when the
Pricing Disclosure Package is delivered to a purchaser, not misleading or (ii)&nbsp;it is necessary to amend or supplement the Pricing Disclosure Package to comply with the Securities Act, the Company will promptly notify the Underwriters thereof
and forthwith prepare and, subject to paragraph&nbsp;(c) above, file with the Commission (to the extent required) and furnish to the Underwriters and to such dealers as the Representatives may designate, such amendments or supplements to the Pricing
Disclosure Package (or any document to be filed with the Commission and incorporated by reference therein) as may be necessary so that the statements in the Pricing Disclosure Package as so amended or supplemented will not, in the light of the
circumstances existing when the Pricing Disclosure Package is delivered to a purchaser, be misleading or so that the Pricing Disclosure Package will comply with the law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Blue Sky Compliance.</I> The Company will qualify the Shares for offer and sale
under the securities or Blue Sky laws of such jurisdictions as the Representatives shall reasonably request and will continue such qualifications in effect so long as required for distribution of the Shares; <U>provided</U> that the Company shall
not be required to (i)&nbsp;qualify as a foreign corporation or other entity or as a dealer in securities in any such jurisdiction where it would not otherwise be required to so qualify, (ii)&nbsp;file any general consent to service of process in
any such jurisdiction or (iii)&nbsp;subject itself to taxation in any such jurisdiction if it is not otherwise so subject. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Earning Statement. </I>The Company will make generally available to its security
holders and the Representatives as soon as practicable an earning statement that satisfies the provisions of Section&nbsp;11(a) of the Securities Act and Rule 158 of the Commission promulgated thereunder covering a period of at least twelve months
beginning with the first fiscal quarter of the Company occurring after the &#147;effective date&#148; (as defined in Rule 158) of the Registration Statement; provided, that, the Company will be deemed to comply with such requirement by filing such
earnings statements on the Commission&#146;s Electronic, Data Gathering, Analysis and Retrieval System (or any successor system). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Clear Market.</I> For a period of 60 days (&#147;Restricted Period&#148;) after the
date of the Prospectus, the Company will not (i)&nbsp;offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer
or dispose of, directly or indirectly, or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman">
submit to, or file with, the Commission a registration statement under the Securities Act relating to, any shares of Stock or any securities convertible into or exercisable or exchangeable for
Stock, or publicly disclose the intention to make any offer, sale, pledge, disposition, submission or filing, or (ii)&nbsp;enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of
the Stock or any such other securities, whether any such transaction described in clause (i)&nbsp;or (ii) above is to be settled by delivery of Stock or such other securities, in cash or otherwise, without the prior written consent of Morgan
Stanley&nbsp;&amp; Co. LLC, other than (A)&nbsp;the Shares to be sold hereunder; (B)&nbsp;any shares of Stock of the Company issued upon the exercise or settlement of awards granted under any&nbsp;stock-based compensation plans of the Company and
its subsidiaries as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus (the &#147;Company Stock Plans&#148;); (C) the grant by the Company of awards under Company Stock Plans, (D)&nbsp;the filing of a
registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-8</FONT> (or equivalent form) in connection with any Company Stock Plan, (E)&nbsp;the issuance of shares of Stock or other securities (including securities convertible into
shares of Stock) in connection with the acquisition by the Company or any of its subsidiaries of the securities, businesses, properties or other assets of another person or entity or pursuant to any employee benefit plan assumed by the Company in
connection with any such acquisition, (F)&nbsp;any shares of Class&nbsp;A common stock to be issued upon conversion of Class&nbsp;B common stock outstanding on the Closing Date and disclosed in the Registration Statement, the Pricing Disclosure
Package and the Prospectus in accordance with the terms of the Company&#146;s amended and restated certificate of incorporation or (G)&nbsp;the issuance of shares of Stock or other securities (including securities convertible into shares of Stock)
in connection with joint ventures, commercial relationships or other strategic transactions;<I>&nbsp;provided</I>&nbsp;that, in the case of clauses (E),&nbsp;(F) and (G), the aggregate number of shares of Stock issued in all such acquisitions and
transactions does not exceed 5% of the outstanding Stock of the Company following the offering of the Shares and any recipients of such Shares shall execute and deliver to Morgan Stanley&nbsp;&amp; Co. LLC a
<FONT STYLE="white-space:nowrap">lock-up</FONT> agreement for the remainder of the Restricted Period substantially in the form of Exhibit&nbsp;A hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Use of Proceeds.</I> The Company will apply the net proceeds from the sale of the
Shares as described in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus under the heading &#147;Use of Proceeds&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No Stabilization.</I> Neither the Company nor its subsidiaries will take, directly
or indirectly, any action designed to or that could reasonably be expected to cause or result in any stabilization or manipulation of the price of the Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Exchange Listing.</I> The Company will use its reasonable best efforts to list,
subject to notice of issuance, the Shares on the NYSE. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Reports</I>. For a
period of five years following the date hereof, so long as the Shares are outstanding, the Company will furnish to the Representatives, as soon as they are available, copies of all reports or other communications (financial or other) furnished to
holders of the Shares, and copies of any reports and financial statements furnished to or filed with the Commission; <I>provided</I> the Company will be deemed to have furnished such reports and financial
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman">
statements to the Representatives to the extent they are filed on the Commission&#146;s Electronic Data Gathering, Analysis, and Retrieval system. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Record Retention</I>. The Company will, pursuant to reasonable procedures developed
in good faith, retain copies of each Issuer Free Writing Prospectus that is not filed with the Commission in accordance with Rule 433 under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Shelf Renewal</I>. If immediately prior to the third anniversary (the &#147;Renewal
Deadline&#148;) of the initial effective date of the Registration Statement, any of the Shares remain unsold by the Underwriters, the Company will, prior to the Renewal Deadline, file, if it has not already done so and is eligible to do so, a new
automatic shelf registration statement relating to the Shares, in a form satisfactory to the Representative. If the Company is not eligible to file an automatic shelf registration statement, the Company will, prior to the Renewal Deadline, if it has
not already done so, file a new shelf registration statement relating to the Shares, in a form satisfactory to the Representative, and will use its best efforts to cause such registration statement to be declared effective within 180 days after the
Renewal Deadline. The Company will take all other action necessary or appropriate to permit the issuance and sale of the Shares to continue as contemplated in the expired registration statement relating to the Shares. References herein to the
Registration Statement shall include such new automatic shelf registration statement or such new shelf registration statement, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Certain Agreements of the Underwriters</U>. Each Underwriter hereby severally represents
and agrees that: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;It has not and will not use, authorize use of, refer to or
participate in the planning for use of, any &#147;free writing prospectus&#148;, as defined in Rule 405 under the Securities Act (which term includes use of any written information furnished to the Commission by the Company and not incorporated by
reference into the Registration Statement and any press release issued by the Company) other than (i)&nbsp;a free writing prospectus that contains no &#147;issuer information&#148; (as defined in Rule 433(h)(2) under the Securities Act) that was not
included (including through incorporation by reference) in the Preliminary Prospectus or a previously filed Issuer Free Writing Prospectus, (ii)&nbsp;any Issuer Free Writing Prospectus listed on Annex A or prepared pursuant to Section&nbsp;3(c) or
Section&nbsp;4(c) above (including any electronic road show approved in advance by the Company), or (iii)&nbsp;any free writing prospectus prepared by such underwriter and approved by the Company in advance in writing (each such free writing
prospectus referred to in clauses&nbsp;(i) or (iii), an &#147;Underwriter Free Writing Prospectus&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;It has not and will not, without the prior written consent of the Company, use any free
writing prospectus that contains the final terms of the offering of the Shares unless such terms have previously been included in a free writing prospectus filed with the Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;It is not subject to any pending proceeding under Section&nbsp;8A of the Securities Act
with respect to the offering (and will promptly notify the Company if any such proceeding against it is initiated during the Prospectus Delivery Period). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions of Underwriters&#146;
Obligations.</U> The obligation of each Underwriter to purchase the Underwritten Shares on the Closing Date or the Option Shares on the Additional Closing Date, as the case may be, as provided herein is subject to the performance by the Company of
its covenants and other obligations hereunder and to the following additional conditions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Registration Compliance; No Stop Order.</I> No order suspending the effectiveness of
the Registration Statement shall be in effect, and no proceeding for such purpose, pursuant to Rule 401(g)(2) or pursuant to Section&nbsp;8A under the Securities Act shall be pending before or, to the knowledge of the Company, threatened by the
Commission; the Prospectus and each Issuer Free Writing Prospectus shall have been timely filed with the Commission under the Securities Act (in the case of an Issuer Free Writing Prospectus, to the extent required by Rule 433 under the Securities
Act) and in accordance with Section&nbsp;4(a) hereof; and all requests by the Commission for additional information shall have been complied with to the reasonable satisfaction of the Representatives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Representations and Warranties.</I> The representations and warranties of the
Company contained herein shall be true and correct on the date hereof and on and as of the Closing Date or the Additional Closing Date, as the case may be; and the statements of the Company and its officers made in any certificates delivered
pursuant to this Agreement shall be true and correct on and as of the Closing Date or the Additional Closing Date, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No Material Adverse Change.</I> No event or condition of a type described in
Section&nbsp;3(g) hereof shall have occurred or shall exist, which event or condition is not described in the Pricing Disclosure Package (excluding any amendment or supplement thereto) and the Prospectus (excluding any amendment or supplement
thereto) and the effect of which in the judgment of the Representatives is so material and adverse as to make it impracticable or inadvisable to proceed with the offering, sale or delivery of the Shares on the Closing Date or the Additional Closing
Date, as the case may be, on the terms and in the manner contemplated by this Agreement, the Pricing Disclosure Package and the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Officers&#146; Certificate.</I> The Representatives shall have received on and as of
the Closing Date or the Additional Closing Date, as the case may be, (x)&nbsp;a certificate of the chief financial officer or chief accounting officer of the Company and one additional senior executive officer of the Company who is satisfactory to
the Representatives (i)&nbsp;confirming that such officers have carefully reviewed the Registration Statement, the Pricing Disclosure Package and the Prospectus and, to the knowledge of such officers, the representations of the Company set forth in
Sections&nbsp;3(b) and 3(d) hereof are true and correct, (ii)&nbsp;confirming that the other representations and warranties of the Company in this Agreement are true and correct and that the Company has complied in all material respects with all
agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date or the Additional Closing Date, as the case may be, and (iii)&nbsp;to the effect set forth in paragraphs&nbsp;(a) and
(c)&nbsp;above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Comfort Letters.</I> On the date
of this Agreement and on the Closing Date or the Additional Closing Date, as the case may be, Deloitte&nbsp;&amp; Touche LLP shall have furnished to the Representatives at the request of the Company, a letter, dated the respective dates of delivery
thereof and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representatives, containing statements and information of the type customarily included in accountants&#146; &#147;comfort letters&#148; to underwriters
with respect to the financial statements and certain financial information contained or incorporated by reference in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus; provided, that the letter delivered on the
Closing Date or the Additional Closing Date, as the case may be, shall use a <FONT STYLE="white-space:nowrap">&#147;cut-off&#148;</FONT> date no more than two business days prior to such Closing Date or such Additional Closing Date, as the case may
be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>CFO Certificate</I>. On the date of this Agreement and on the Closing Date
or the Additional Closing Date, as the case may be, the Company shall have furnished to the Representative a certificate, dated the respective dates of delivery thereof and addressed to the Underwriters, of its chief financial officer with respect
to certain financial data contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus, providing &#147;management comfort&#148; with respect to such information, in form and substance reasonably satisfactory to the
Representatives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Opinion and <FONT STYLE="white-space:nowrap">10b-5</FONT>
Statement of Counsel for the Company.</I> Kirkland&nbsp;&amp; Ellis LLP, counsel for the Company, shall have furnished to the Representatives, at the request of the Company, their written opinion and <FONT STYLE="white-space:nowrap">10b-5</FONT>
statement, dated the Closing Date or the Additional Closing Date, as the case may be, and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representatives, to the effect set forth in Annex B hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Opinion and <FONT STYLE="white-space:nowrap">10b-5</FONT> Statement of Counsel for
the Underwriters.</I> The Representatives shall have received on and as of the Closing Date or the Additional Closing Date, as the case may be, an opinion and <FONT STYLE="white-space:nowrap">10b-5</FONT> statement, addressed to the Underwriters, of
Davis Polk&nbsp;&amp; Wardwell LLP, counsel for the Underwriters, with respect to such matters as the Representatives may reasonably request, and such counsel shall have received such documents and information as they may reasonably request to
enable them to pass upon such matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No Legal Impediment to Issuance and/or
Sale.</I> No action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing Date or the Additional
Closing Date, as the case may be, prevent the issuance or sale of the Shares; and no injunction or order of any federal, state or foreign court shall have been issued that would, as of the Closing Date or the Additional Closing Date, as the case may
be, prevent the issuance or sale of the Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Good Standing</I>. The
Representatives shall have received on and as of the Closing Date or the Additional Closing Date, as the case may be, satisfactory evidence of the good standing of the Company in its jurisdiction of organization, in each case in writing or any
standard form of telecommunication from the appropriate governmental </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman">
authority in such jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Exchange Listing.</I> The Shares to be delivered on the Closing Date or the
Additional Closing Date, as the case may be, shall have been approved for listing on the NYSE, subject to official notice of issuance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><FONT STYLE="white-space:nowrap">Lock-up</FONT> Agreements</I>. The <FONT
STYLE="white-space:nowrap">&#147;lock-up&#148;</FONT> agreements, each substantially in the form of Exhibit A hereto, between you and each of the shareholders, officers and directors of the Company named on Schedule 2 hereto relating to sales and
certain other dispositions of shares of Stock or certain other securities, delivered to you on or before the date hereof, shall be in full force and effect on the Closing Date or the Additional Closing Date, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Additional Documents.</I> On or prior to the Closing Date or the Additional Closing
Date, as the case may be, the Company shall have furnished to the Representatives such further certificates and documents as the Representatives may reasonably request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">All opinions, letters, certificates and evidence mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the
provisions hereof only if they are in form and substance reasonably satisfactory to counsel for the Underwriters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification and Contribution</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Indemnification of the Underwriters.</I> The Company agrees to indemnify and hold
harmless each Underwriter, its affiliates, directors and officers and each person, if any, who controls such Underwriter within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act, from and against any and all
losses, claims, damages and liabilities (including, without limitation, legal fees and other expenses incurred in connection with any suit, action or proceeding or any claim asserted, as such fees and expenses are reasonably incurred), joint or
several, that arise out of, or are based upon, (i)&nbsp;any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or caused by any omission or alleged omission to state therein a material fact
required to be stated therein or necessary in order to make the statements therein, not misleading, or (ii)&nbsp;any untrue statement or alleged untrue statement of a material fact contained in the Prospectus (or any amendment or supplement
thereto), the Preliminary Prospectus, any Issuer Free Writing Prospectus, any &#147;issuer information&#148; filed or required to be filed pursuant to Rule 433(d) under the Securities Act, any road show as defined in Rule 433(h) under the Securities
Act (a &#147;road show&#148;) or any Pricing Disclosure Package (including any Pricing Disclosure Package that has subsequently been amended), or caused by any omission or alleged omission to state therein a material fact necessary in order to make
the statements therein, in light of the circumstances under which they were made, not misleading, in each case except insofar as such losses, claims, damages or liabilities arise out of, or are based upon, any untrue statement or omission or alleged
untrue statement or omission made in reliance upon and in conformity with any information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman">
therein, it being understood and agreed that the only such information furnished by any Underwriter consists of the Underwriter Information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Indemnification of the Company.</I> Each Underwriter agrees, severally and not
jointly, to indemnify and hold harmless the Company, its directors, its officers who signed the Registration Statement and each person, if any, who controls the Company within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20
of the Exchange Act to the same extent as the indemnity set forth in paragraph&nbsp;(a) above, but only with respect to any losses, claims, damages or liabilities that arise out of, or are based upon, any untrue statement or omission or alleged
untrue statement or omission made in reliance upon and in conformity with any information relating to such Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in the Registration
Statement, the Prospectus (or any amendment or supplement thereto), the Preliminary Prospectus, any Issuer Free Writing Prospectus, any road show or any Pricing Disclosure Package (including any Pricing Disclosure Package that has subsequently been
amended), it being understood and agreed upon that the only such information furnished by any Underwriter consists of the following information in the Prospectus furnished on behalf of each Underwriter: the information contained in the paragraph
under the caption &#147;Underwriting&#151;Price Stabilization and Short Positions&#148; relating to price stabilization and short positions (the &#147;Underwriter Information&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Notice and Procedures.</I> If any suit, action, proceeding (including any
governmental or regulatory investigation), claim or demand shall be brought or asserted against any person in respect of which indemnification may be sought pursuant to the preceding paragraphs of this Section&nbsp;7, such person (the
&#147;Indemnified Person&#148;) shall promptly notify the person against whom such indemnification may be sought (the &#147;Indemnifying Person&#148;) in writing; <U>provided</U> that the failure to notify the Indemnifying Person shall not relieve
it from any liability that it may have under the preceding paragraphs of this Section&nbsp;7 except to the extent that it has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure; and <U>provided,
further,</U> that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have to an Indemnified Person otherwise than under the preceding paragraphs of this Section&nbsp;7. If any such proceeding shall be
brought or asserted against an Indemnified Person and it shall have notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably satisfactory to the Indemnified Person (who shall not, without the consent of the
Indemnified Person, be counsel to the Indemnifying Person) to represent the Indemnified Person and any others entitled to indemnification pursuant to this Section that the Indemnifying Person may designate in such proceeding and shall pay the fees
and expenses in such proceeding and shall pay the fees and expenses of such counsel related to such proceeding, as reasonably incurred. In any such proceeding, any Indemnified Person shall have the right to retain its own counsel, but the fees and
expenses of such counsel shall be at the expense of such Indemnified Person unless (i)&nbsp;the Indemnifying Person and the Indemnified Person shall have mutually agreed to the contrary; (ii)&nbsp;the Indemnifying Person has failed within a
reasonable time to retain counsel reasonably satisfactory to the Indemnified Person; (iii)&nbsp;the Indemnified Person shall have reasonably concluded based on the advice of counsel that there may be legal defenses available to it that are
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman">
different from or in addition to those available to the Indemnifying Person; or (iv)&nbsp;the named parties in any such proceeding (including any impleaded parties) include both the Indemnifying
Person and the Indemnified Person and it can be reasonably concluded that representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. It is understood and agreed that the
Indemnifying Person shall not, in connection with any proceeding or related proceeding in the same jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to any one local counsel in each applicable
jurisdiction) for all Indemnified Persons, and that all such fees and expenses shall be paid or reimbursed promptly as they are reasonably incurred. Any such separate firm for any Underwriter, its affiliates, directors and officers and any control
persons of such Underwriter shall be designated in writing by the Representatives, any such separate firm for the Company, its directors, its officers who signed the Registration Statement and any control persons of the Company shall be designated
in writing by the Company. The Indemnifying Person shall not be liable for any settlement of any proceeding effected without its written consent (which shall not be unreasonably withheld, delayed or conditioned), but if settled with such consent or
if there be a final judgment for the plaintiff, the Indemnifying Person agrees to indemnify each Indemnified Person from and against any loss or liability by reason of such settlement or judgment. No Indemnifying Person shall, without the written
consent of the Indemnified Person, effect any settlement of any pending or threatened proceeding in respect of which any Indemnified Person is or could have been a party and indemnification could have been sought hereunder by such Indemnified
Person, unless such settlement (x)&nbsp;includes an unconditional release of such Indemnified Person, in form and substance reasonably satisfactory to such Indemnified Person, from all liability on claims that are the subject matter of such
proceeding and (y)&nbsp;does not include any statement as to or any admission of fault, culpability or a failure to act by or on behalf of any Indemnified Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Contribution.</I> If the indemnification provided for in paragraphs (a)&nbsp;or (b)
above is unavailable to an Indemnified Person or insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under such paragraph, in lieu of indemnifying such Indemnified Person
thereunder, shall contribute to the amount paid or payable by such Indemnified Person as a result of such losses, claims, damages or liabilities (i)&nbsp;in such proportion as is appropriate to reflect the relative benefits received by the Company,
on the one hand, and the Underwriters on the other, from the offering of the Shares or (ii)&nbsp;if the allocation provided by clause&nbsp;(i) is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative
benefits referred to in clause&nbsp;(i) but also the relative fault of the Company, on the one hand, and the Underwriters on the other, in connection with the statements or omissions that resulted in such losses, claims, damages or liabilities, as
well as any other relevant equitable considerations. The relative benefits received by the Company, on the one hand, and the Underwriters on the other, shall be deemed to be in the same respective proportions as the net proceeds (before deducting
expenses) received by the Company from the sale of the Shares and the total underwriting discounts and commissions received by the Underwriters in connection therewith, in each case as set forth in the table on the cover of the Prospectus, bear to
the aggregate offering price of the Shares. The relative fault of the Company, on the one hand, and the Underwriters on the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman">
other, shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact
relates to information supplied by the Company or by the Underwriters and the parties&#146; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Limitation on Liability.</I> The Company and the Underwriters agree that it would
not be just and equitable if contribution pursuant to paragraph (d)&nbsp;above were determined by <U>pro</U> <U>rata</U> allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation that does
not take account of the equitable considerations referred to in paragraph&nbsp;(d) above. The amount paid or payable by an Indemnified Person as a result of the losses, claims, damages and liabilities referred to in paragraph&nbsp;(d) above shall be
deemed to include, subject to the limitations set forth above, any legal or other expenses reasonably incurred by such Indemnified Person in connection with any such action or claim. Notwithstanding the provisions of paragraphs&nbsp;(d) and (e), in
no event shall an Underwriter be required to contribute any amount in excess of the amount by which the total underwriting discounts and commissions received by such Underwriter with respect to the offering of the Shares exceeds the amount of any
damages that such Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the
Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The Underwriters&#146; obligations to contribute pursuant to paragraphs&nbsp;(d) and (e)&nbsp;are several in proportion to
their respective purchase obligations hereunder and not joint. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><FONT
STYLE="white-space:nowrap">Non-Exclusive</FONT> Remedies.</I> The remedies provided for in this Section&nbsp;7 paragraphs&nbsp;(a) through (e)&nbsp;are not exclusive and shall not limit any rights or remedies which may otherwise be available to any
Indemnified Person at law or in equity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Effectiveness of Agreement</U>. This
Agreement shall become effective as of the date first written above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination</U>. This Agreement may be terminated in the absolute discretion of the
Representatives, by notice to the Company, if after the execution and delivery of this Agreement and on or prior to the Closing Date or, in the case of the Option Shares, on or prior to the Additional Closing Date (i)&nbsp;trading generally shall
have been suspended or materially limited on or by any of the New York Stock Exchange; (ii)&nbsp;trading of any securities issued or guaranteed by the Company shall have been suspended on any exchange or in any <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market; (iii)&nbsp;a general moratorium on commercial banking activities shall have been declared by federal or New York State authorities; or (iv)&nbsp;there shall have occurred any outbreak
or escalation of hostilities or any change in financial markets or any calamity or crisis, either within or outside the United States, that, in the judgment of the Representatives, is material and adverse and makes it impracticable or inadvisable to
proceed with the offering, sale or delivery of the Shares on the Closing Date or the Additional Closing Date, as the case may be, on the terms and in the manner contemplated by this Agreement, the Pricing Disclosure Package and the Prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Defaulting Underwriter</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If, on the Closing Date or the Additional Closing Date, as the case may be, any
Underwriter defaults on its obligation to purchase the Shares that it has agreed to purchase hereunder on such date, the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters may in their discretion arrange for the purchase of such
Shares by other persons satisfactory to the Company on the terms contained in this Agreement. If, within 36 hours after any such default by any Underwriter, the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters do not arrange for
the purchase of such Shares, then the Company shall be entitled to a further period of 36 hours within which to procure other persons satisfactory to the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters to purchase such Shares on
such terms. If other persons become obligated or agree to purchase the Shares of a defaulting Underwriter, either the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters or the Company may postpone the Closing Date or the Additional
Closing Date, as the case may be, for up to five full business days in order to effect any changes that in the opinion of counsel for the Company or counsel for the Underwriters may be necessary in the Registration Statement and the Prospectus or in
any other document or arrangement, and the Company agrees to promptly prepare any amendment or supplement to the Registration Statement and the Prospectus that effects any such changes. As used in this Agreement, the term &#147;Underwriter&#148;
includes, for all purposes of this Agreement unless the context otherwise requires, any person not listed in Schedule 1 hereto that, pursuant to this Section&nbsp;10, purchases Shares that a defaulting Underwriter agreed but failed to purchase. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If, after giving effect to any arrangements for the purchase of the Shares of a
defaulting Underwriter or Underwriters by the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters and the Company as provided in paragraph&nbsp;(a) above, the aggregate number of Shares that remain unpurchased on the Closing Date or
the Additional Closing Date, as the case may be, does not exceed <FONT STYLE="white-space:nowrap">one-eleventh</FONT> of the aggregate number of Shares to be purchased on such date, then the Company shall have the right to require each <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter to purchase the number of Shares that such Underwriter agreed to purchase hereunder on such date plus such Underwriter&#146;s pro rata share (based on the number of Shares that such
Underwriter agreed to purchase on such date) of the Shares of such defaulting Underwriter or Underwriters for which such arrangements have not been made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If, after giving effect to any arrangements for the purchase of the Shares of a
defaulting Underwriter or Underwriters by the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters and the Company as provided in paragraph&nbsp;(a) above, the aggregate number of Shares that remain unpurchased on the Closing Date or
the Additional Closing Date, as the case may be, exceeds <FONT STYLE="white-space:nowrap">one-eleventh</FONT> of the aggregate amount of Shares to be purchased on such date, or if the Company shall not exercise the right described in
paragraph&nbsp;(b) above, then this Agreement or, with respect to any Additional Closing Date, the obligation of the Underwriters to purchase Shares on the Additional Closing Date, as the case may be, shall terminate without liability on the part of
the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters. Any termination of this Agreement pursuant to this Section&nbsp;10 shall be without liability on the part of the Company, except that the Company will continue to be liable for
the payment of expenses as set forth in Section&nbsp;10 hereof and except that the provisions of Section&nbsp;7 hereof shall not terminate and shall remain in effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nothing contained herein shall
relieve a defaulting Underwriter of any liability it may have to the Company or any <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter for damages caused by its default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment of Expenses</U><I>.</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Whether or not the transactions contemplated by this Agreement are consummated or this
Agreement is terminated, the Company will pay or cause to be paid all costs and expenses incident to the performance of its obligations hereunder, including without limitation, (i)&nbsp;the costs incident to the authorization, issuance, sale,
preparation and delivery of the Shares and any taxes payable in that connection; (ii)&nbsp;the costs incident to the preparation, printing and filing under the Securities Act of the Registration Statement, the Preliminary Prospectus, any Issuer Free
Writing Prospectus, any Pricing Disclosure Package and the Prospectus (including all exhibits, amendments and supplements thereto) and the distribution thereof; (iii)&nbsp;the fees and expenses of the Company&#146;s counsel and independent
accountants; (iv)&nbsp;the fees and expenses incurred in connection with the registration or qualification and determination of eligibility for investment of the Shares under the laws of such jurisdictions as the Representatives may designate and
the preparation, printing and distribution of a Blue Sky Memorandum (including the related fees and expenses of counsel for the Underwriters);&nbsp;(v)&nbsp;the costs and charges of any transfer agent and any registrar; (vi)&nbsp;all expenses and
application fees incurred in connection with any filing with, and clearance of the offering by, FINRA; (vii)&nbsp;all expenses incurred by the Company in connection with any &#147;road show&#148; presentation to potential investors; except that it
is understood that 50% of the cost of any chartered aircraft and other transportation chartered in connection with the &#147;road show&#148; shall be the responsibility of the Underwriters; and (viii)&nbsp;all expenses and application fees related
to the listing of the Shares on the NYSE. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If (i)&nbsp;this Agreement is terminated
pursuant to Section&nbsp;9, (ii)&nbsp;the Company for any reason fail to tender the Shares for delivery to the Underwriters or (iii)&nbsp;the Underwriters decline to purchase the Shares for any reason permitted under this Agreement, the Company
agrees to reimburse the Underwriters for all documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses (including the reasonable fees and expenses of their counsel) reasonably
incurred by the Underwriters in connection with this Agreement and the offering contemplated hereby. The Company shall not be required to pay or reimburse any costs, fees or expenses incurred by any Underwriter that defaults on its obligations to
purchase the Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Persons Entitled to Benefit of Agreement</U>. This Agreement shall inure
to the benefit of and be binding upon the parties hereto and their respective successors and the officers and directors and any controlling persons referred to herein and the affiliates of each Underwriter referred to in Section&nbsp;7 hereof.
Nothing in this Agreement is intended or shall be construed to give any other person any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein. No purchaser of Shares from any Underwriter
shall be deemed to be a successor merely by reason of such purchase. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Survival</U>. The respective indemnities, rights
of contribution, representations, warranties and agreements of the Company and the Underwriters contained in this Agreement or made by or on behalf of the Company or the Underwriters pursuant to this Agreement or any certificate delivered pursuant
hereto shall survive the delivery of and payment for the Shares and shall remain in full force and effect, regardless of any termination of this Agreement or any investigation made by or on behalf of the Company or the Underwriters or the directors,
officers, controlling persons or affiliates referred to in Section&nbsp;7 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Certain
Defined Terms</U>. For purposes of this Agreement, (a)&nbsp;except where otherwise expressly provided, the term &#147;affiliate&#148; has the meaning set forth in Rule 405 under the Securities Act; (b)&nbsp;the term &#147;business day&#148; means
any day other than a day on which banks are permitted or required to be closed in New York City; and (c)&nbsp;the term &#147;subsidiary&#148; has the meaning set forth in Rule 405 under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance with USA Patriot Act</U>. In accordance with the requirements of the USA Patriot Act
(Title III of Pub. L. <FONT STYLE="white-space:nowrap">107-56</FONT> (signed into law October&nbsp;26, 2001)), the Underwriters are required to obtain, verify and record information that identifies their respective clients, including the Company,
which information may include the name and address of their respective clients, as well as other information that will allow the Underwriters to properly identify their respective clients. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Miscellaneous</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Notices.</I> All notices and other communications hereunder shall be in writing and
shall be deemed to have been duly given if mailed or transmitted and confirmed by any standard form of telecommunication. Notices to the Underwriters shall be given to the Representatives c/o Morgan Stanley&nbsp;&amp; Co. LLC, 1585 Broadway, New
York, New York 10036, Attention: Equity Syndicate Desk. Notices to the Company shall be given to it at 1855 Griffin Road, Suite <FONT STYLE="white-space:nowrap">B-428,</FONT> Dania Beach, Florida 33004; Attention: General Counsel, with a copy to
(which copy shall not constitute notice): Kirkland&nbsp;&amp; Ellis LLP, 601 Lexington Avenue, New York, New York, 10022, Attention: Joshua N. Korff and Tim Cruickshank. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Governing Law.</I> This Agreement and any claim, controversy or dispute arising
under or related to this Agreement shall be governed by and construed in accordance with the laws of the State of New York. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Submission to Jurisdiction</I>. The Company hereby submits to the exclusive
jurisdiction of the U.S. federal and New York state courts in the Borough of Manhattan in The City of New York in any suit or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby. The Company waives any
objection which it may now or hereafter have to the laying of venue of any such suit or proceeding in such courts. The Company agrees that final judgment in any such suit, action or proceeding brought in such court shall be conclusive and binding
upon the Company and may be enforced in any court to the jurisdiction of which the Company is subject by a suit upon such judgment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Waiver of Jury Trial.</I> Each of
the parties hereto hereby waives any right to trial by jury in any suit or proceeding arising out of or relating to this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Recognition of the U.S. Special Resolution Regimes</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:11%; font-size:12pt; font-family:Times New Roman">(i) In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the
transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any
such interest and obligation, were governed by the laws of the United States or a state of the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:11%; font-size:12pt; font-family:Times New Roman">(ii) In the event that any
Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted
to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:11%; font-size:12pt; font-family:Times New Roman">As used in this Section&nbsp;16(e): </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:11%; font-size:12pt; font-family:Times New Roman">&#147;BHC Act Affiliate&#148; has the meaning assigned to the term &#147;affiliate&#148; in, and shall be interpreted in accordance with, 12
U.S.C. &#167; 1841(k). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:11%; font-size:12pt; font-family:Times New Roman">&#147;Covered Entity&#148; means any of the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:12pt; font-family:Times New Roman">(i) a &#147;covered entity&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:12pt; font-family:Times New Roman">(ii) a &#147;covered bank&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b); or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:12pt; font-family:Times New Roman">(iii) a &#147;covered FSI&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:11%; font-size:12pt; font-family:Times New Roman">&#147;Default Right&#148; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167;
252.81, 47.2 or 382.1, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;U.S. Special Resolution Regime&#148;
means each of (i)&nbsp;the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii)&nbsp;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Counterparts.</I> This Agreement may be signed in counterparts (which may include
counterparts delivered by any standard form of telecommunication), each of which shall be an original and all of which together shall constitute one and the same instrument. This Agreement may be delivered via facsimile, electronic mail (including
pdf or any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman">
electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com or www.echosign.com) or other transmission method and any counterpart so delivered shall be deemed
to have been duly and validly delivered and be valid and effective for all purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Amendments or Waivers.</I> No amendment or waiver of any provision of this
Agreement, nor any consent or approval to any departure therefrom, shall in any event be effective unless the same shall be in writing and signed by the parties hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; text-indent:5%; font-size:12pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Headings.</I> The headings herein are included for convenience of reference only and
are not intended to be part of, or to affect the meaning or interpretation of, this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page Follows</I>] </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:12pt; font-family:Times New Roman">If the foregoing is in accordance with your understanding, please indicate your acceptance
of this Agreement by signing in the space provided below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" COLSPAN="3">CHEWY, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><U>/s/ Susan Helfrick</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name: Susan Helfrick</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title: General Counsel</TD></TR>
</TABLE></DIV> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Underwriting Agreement] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Accepted: As of the date first written above </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">MORGAN STANLEY&nbsp;&amp; CO. LLC </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">For itself and on behalf of
the </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">several Underwriters listed </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">in Schedule 1 hereto. </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">By: <U>/s/ Jacqueline Murphy </U> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Name: Jacqueline Murphy </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Title: Vice President </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Underwriting Agreement] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="right"><B>Schedule 1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="90%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt">


<TR>

<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B><U>Underwriter</U></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B><U>Number&nbsp;of&nbsp;Shares</U></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,100,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Total:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,100,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule 1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="right"><B>Schedule 2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">Lock-up</FONT> Parties </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">Sumit Singh </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">Mario Marte </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">Satish Mehta </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">Susan Helfrick </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">Stacy Bowman </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">Raymond Svider </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">Fahim Ahmed </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">Michael Chang </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">James Kim </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">David Leland </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">Brian McAndrews </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">Sharon McCollam </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">Lisa Sibenac </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">14.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">J.K. Symancyk </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">15.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">James A. Star </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">16.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">PetSmart, Inc. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">17.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">PetSmart Buddy Holdings Corp. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">18.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">Buddy Chester Corp. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">19.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">Argos Holdings L.P. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">20.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">Buddy Holdings Corp. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule 2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="right"><B>Annex A </B></P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">a.<B> Pricing Disclosure Package</B> </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:8%; font-size:12pt; font-family:Times New Roman">None.
</P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">b. <B>Pricing Information Provided Orally by Underwriters</B> </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:8%; font-size:12pt; font-family:Times New Roman">Underwritten Shares: 5,100,000 shares </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:8%; font-size:12pt; font-family:Times New Roman">Option Shares: 765,000 shares </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:8%; font-size:12pt; font-family:Times New Roman">Price per share: Price per share paid by each applicable investor. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex&nbsp;A </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="right"><B>Annex B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>[Form of Opinion of Counsel for the Company] </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">Based solely on our review of the Company Good Standing Certificate, the Company validly exists as a
corporation and is in good standing under the General Corporation Law of the State of Delaware (&#147;<U>DGCL</U>&#148;). </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">The Company has the corporate power and authority to own and lease its properties and conduct its business as
described in the Time of Sale Information and the Prospectus. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">The Securities to be sold by the Company have been duly authorized and, when delivered and paid for in
accordance with the Underwriting Agreement, will be validly issued, fully paid, and nonassessable and will not have been issued in violation of or subject to preemptive rights under the DGCL or any Specified Contract that entitled or will entitle
any person to acquire any shares from the Company upon issuance or sale thereof. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">The Underwriting Agreement has been duly authorized, executed and delivered by the Company.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">The execution and delivery of the Underwriting Agreement by the Company, and the issuance and sale of the
Securities to you, do not and will not (i)&nbsp;conflict with or violate any of the terms or provisions of the Company Certificate of Incorporation and Company Bylaws, (ii)&nbsp;result in any breach of any of the terms and provisions of, or
constitute a default (or an event which with notice or lapse of time, or both, would constitute a default) under any Specified Contracts, it being expressly understood that in each case we express no opinion as to compliance with any financial
covenant or test or cross-default provision in any Specified Contract, (iii)&nbsp;violate or conflict with any judgment, decree or order identified to us by the Company (we note that none were identified) of any court or any judicial, regulatory or
other legal or governmental agency or body having jurisdiction over the Company or any of its subsidiaries or any of their properties, and (iv)&nbsp;violate any Specified Law, except in the case of clause (ii), for any such conflict, breach,
violation or default which has been waived by the party or parties with power to waive such conflict, breach, violation or default. (The advice in this paragraph is referred to herein as the &#147;<U>No Conflicts Opinion</U>&#148;).
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">No consent, approval, authorization, or order of, or qualification with, any governmental body or agency under
any Specified Law is required to be obtained by the Company with respect to the issuance and sale of the Securities and the execution, delivery and performance by the Company of its obligations under the Underwriting Agreement. (The advice in this
paragraph is referred to herein as the &#147;<U>No Consent Opinion</U>&#148;). </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">Based solely upon our review of the Specified Contracts, except as otherwise disclosed in the Registration
Statement, the Time of Sale Information and the Prospectus, the Company is not a party to any agreement that would require the inclusion in the Registration Statement of shares or other securities owned by any person or entity other than the
Company. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">The Time of Sale Information, as of 4:10 p.m. on September&nbsp;16, 2020, the Registration Statement, as of its
effective date and the Prospectus, as of its date, appeared on their face to be appropriately responsive in all material respects to the requirements as to form of the Securities Act and the applicable rules and regulations thereunder, except that
in each case </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
(i)&nbsp;we do not express any opinion as to any financial statements or supporting schedules (or any notes to any such statements or schedules) or other financial information derived therefrom,
in each case in (or omitted from) the Time of Sale Information, the Registration Statement or the Prospectus and (ii)&nbsp;we do not, other than expressly stated in paragraph&nbsp;9 immediately below, assume any responsibility for the accuracy,
completeness or fairness of the statements contained in the Time of Sale Information, the Registration Statement or the Prospectus. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">The statements under the captions &#147;Description of Common Stock&#148; and &#147;Material U.S. Federal
Income Tax Consequences for <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders&#148; in the Time of Sale Information and the Prospectus, insofar as such statements constitute a summary of the legal matters or documents referred to therein, are
accurate in all material respects. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">The Company is not, and immediately after giving effect to the offering and sale of the Securities and the
application of the proceeds thereof as described under &#147;Use of Proceeds&#148; in the Time of Sale Information and the Prospectus will not be, required to register as an &#147;investment company&#148; as such term is defined in the Investment
Company Act of 1940, as amended. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:12pt; font-family:Times New Roman">Based on the foregoing (relying as to matters of fact to a large extent on statements
of officers and other representatives of the Company), we can advise you that nothing has come to our attention that has caused us to conclude that (a)&nbsp;the Registration Statement, when it became effective, which for the purposes of this letter
shall mean September&nbsp;16, 2020, contained any untrue statement of a material fact or omitted to state any material fact required to be stated therein or necessary to make the statements therein not misleading, (b)&nbsp;the Time of Sale
Information as of 4:10 p.m., New York City time, on the date of the Underwriting Agreement, contained any untrue statement of a material fact or omitted to state any material fact necessary in order to make the statements therein, in the light of
the circumstances under which they were made, not misleading, or (c)&nbsp;the Prospectus as of its date or the date hereof, contained or contains any untrue statement of a material fact or omitted or omits to state any material fact necessary in
order to make the statements therein, in the light of the circumstances under which they were made, not misleading. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex&nbsp;B </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>FORM OF <FONT STYLE="white-space:nowrap">LOCK-UP</FONT> AGREEMENT </B></P>
<P STYLE="margin-top:36pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="right">, 2020 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">1585 Broadway </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">New York, NY 10036 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:12pt; font-family:Times New Roman">Re: Chewy, Inc. &#151; Public Offering </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Ladies
and Gentlemen: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:12pt; font-family:Times New Roman">The undersigned understands that you, as Representatives of the several Underwriters, propose to enter into an
underwriting agreement (the &#147;Underwriting Agreement&#148;) with Chewy, Inc., a Delaware corporation (the &#147;Company&#148;), providing for the public offering (the &#147;Public Offering&#148;) by the several Underwriters named in Schedule 1
to the Underwriting Agreement (the &#147;Underwriters&#148;), of shares (the &#147;Securities&#148;) of Class&nbsp;A common stock, par value $0.01 per share, of the Company (the &#147;Class&nbsp;A Common Stock&#148;). Capitalized terms used herein
and not otherwise defined shall have the meanings set forth in the Underwriting Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:12pt; font-family:Times New Roman">In consideration of the Underwriters&#146;
agreement to purchase and make the Public Offering of the Securities, and for other good and valuable consideration receipt of which is hereby acknowledged, the undersigned hereby agrees that, without the prior written consent of Morgan
Stanley&nbsp;&amp; Co. LLC (the <FONT STYLE="white-space:nowrap">&#147;Lock-up</FONT> Release Agent&#148;) on behalf of the Underwriters, the undersigned will not, and will not cause any of its affiliates to, during the period from the date hereof
and ending 60 days after the date of the final prospectus relating to the Public Offering (the &#147;Prospectus&#148; and such period, the <FONT STYLE="white-space:nowrap">&#147;Lock-up</FONT> Period&#148;), (1) offer, pledge, sell, contract to
sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any shares of Class&nbsp;A Common Stock or
Class&nbsp;B common stock, par value $0.01 per share of the Company (&#147;Class&nbsp;B Common Stock&#148;, and, together with the Class&nbsp;A Common Stock, the &#147;Common Stock&#148;) or any securities convertible into or exercisable or
exchangeable for shares of Common Stock (including without limitation, Common Stock or such other securities which may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange
Commission and securities which may be issued upon exercise of a stock option or warrant), or publicly disclose the intention to make any offer, sale, pledge or disposition, (2)&nbsp;enter into any swap or other agreement that transfers, in whole or
in part, any of the economic consequences of ownership of the Common Stock or such other securities, whether any such transaction described in clause (1)&nbsp;or (2) above is to be settled by delivery of Common Stock or such other securities, in
cash or otherwise or (3)&nbsp;make any demand for or exercise any right with respect to the registration of any shares of Common Stock or any security convertible into or exercisable or exchangeable for Common Stock. The undersigned acknowledges and
agrees that </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit A </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
the foregoing precludes the undersigned from engaging in any hedging or other transactions designed or intended, or which could reasonably be expected to lead to or result in, a sale or
disposition of any shares of Common Stock, or securities convertible into or exercisable or exchangeable for Common Stock, even if any such sale or disposition transaction or transactions would be made or executed by or on behalf of someone other
than the undersigned. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:12pt; font-family:Times New Roman">Notwithstanding the foregoing, the terms of this Letter Agreement shall not apply to or prohibit: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">[reserved]; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">transfers of shares of Common Stock or any securities convertible into or exercisable or exchangeable for
shares of Common Stock (i)&nbsp;as a <I>bona fide </I>gift or gifts, (ii)&nbsp;to any immediate family member of the undersigned or any trust for the direct or indirect benefit of the undersigned or any immediate family member of the undersigned
(for purposes of this Letter Agreement, &#147;immediate family&#148; shall mean any relationship by blood, marriage or adoption, not more remote than first cousin); (iii) to a corporation, partnership, limited liability company, trust or other
entity of which the undersigned and the immediate family of the undersigned are the legal and beneficial owner of all of the outstanding equity securities or similar interests; or (iv)&nbsp;to a nominee or custodian of a person or entity to whom a
disposition or transfer would be permissible under clauses (i)&nbsp;through (iii) above; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">if the undersigned is a corporation, partnership, limited liability company or other business entity, transfers
or distributions of shares of Common Stock or any securities convertible into or exercisable or exchangeable for shares of Common Stock to (i)&nbsp;its limited or general partners, members or stockholders or (ii)&nbsp;its affiliates or other
entities controlled or managed by the undersigned or any of its affiliates (other than the Company and its subsidiaries); </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(D)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">the transfer or disposition of any shares of Common Stock purchased by the undersigned on the open market
following the Public Offering; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(E)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">the entering into by the undersigned of a written trading plan (&#147;Rule
<FONT STYLE="white-space:nowrap">10b5-1</FONT> Plan&#148;) pursuant to Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;) during the
<FONT STYLE="white-space:nowrap">Lock-up</FONT> Period, provided that no sales or transfers of shares of the undersigned&#146;s Common Stock shall be made pursuant to such Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> Plan prior to the
expiration of the <FONT STYLE="white-space:nowrap">Lock-up</FONT> Period and no filing under the Exchange Act or other public announcement shall be required or voluntarily made by the undersigned or any other person in connection therewith without
the permission of the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Release Agent, prior to the expiration of the <FONT STYLE="white-space:nowrap">Lock-up</FONT> Period; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(F)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">the transfer of shares of Common Stock pursuant to a bona fide third-party tender offer, merger, consolidation
or other similar transaction made to all or substantially all holders of the Company&#146;s capital stock involving a change of control of the Company (for purposes of this Letter Agreement, &#147;change of control&#148; shall mean any bona fide
third </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit A </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
party tender offer, merger, consolidation or other similar transaction approved by the board of directors of the Company the result of which is that any &#147;person&#148; (as defined in
Section&nbsp;13(d)(3) of the Exchange Act), or group of persons, shall become, after the closing of the transaction, the beneficial owner (as defined in Rules <FONT STYLE="white-space:nowrap">13d-3</FONT> and
<FONT STYLE="white-space:nowrap">13d-5</FONT> of the Exchange Act) of more than 50% of total voting power of the voting securities of the Company), provided that in the event that such tender offer, merger, consolidation or other such transaction is
not completed, the undersigned&#146;s shares of Common Stock shall remain subject to the provisions of this Letter Agreement during the <FONT STYLE="white-space:nowrap">Lock-up</FONT> Period; </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(G)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">the transfer or disposition of any shares of Common Stock (i)&nbsp;as a result of the operation of law, or
pursuant to an order of a court (including a domestic order, divorce settlement, divorce decree, or separation agreement) or regulatory agency or (ii)&nbsp;by will, other testamentary document or intestate succession; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(H)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">any pledge by PetSmart Buddy Holdings Corp. (or any permitted transferee) of shares of Common Stock or such
other securities of the Company pursuant to agreements governing indebtedness or commitments relating to indebtedness of PetSmart Buddy Holdings Corp. (or any permitted transferee) or its affiliates (other than the Company and its subsidiaries)
which is outstanding on the date hereof and described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, and any refinancing of such indebtedness or commitments, <U>provided</U> that no filing by the undersigned or any
party (pledgor or pledgee) under the Exchange Act, or other public announcement, shall be made voluntarily in connection therewith, and if any report is required to be filed under the Exchange Act related thereto during the <FONT
STYLE="white-space:nowrap">Lock-up</FONT> Period, the undersigned shall provide the Representatives prior written notice informing them of such report; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(I)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">the repurchase of the Common Stock or such other securities by the Company pursuant to equity award agreements
or other contractual arrangements providing for the right of said repurchase in connection with the termination of the undersigned&#146;s employment or service with the Company; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(J)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">transfers or sales of the Common Stock pursuant to any Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> Plan
that has been entered into by the undersigned prior to the date of this Letter Agreement, provided that any filing required to be made under Section&nbsp;16(a) of the Exchange Act as a result of such transfer or sale shall state that such transfer
or sale is pursuant to a trading plan pursuant to Rule <FONT STYLE="white-space:nowrap">10b5-1;</FONT> and </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(K)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">(i) transfers of Common Stock (or any security convertible into Common Stock) to the Company upon the vesting
or settlement of restricted stock units or other equity-based awards granted under an equity incentive plan or stock purchase plan of the Company, in each case on a &#147;cashless&#148; or &#147;net exercise&#148; basis or to cover tax withholding
and remittance obligations of the undersigned in connection with such vesting or settlement or (ii)&nbsp;transfer or sales of Common Stock (or any security convertible into Common Stock) following the vesting or settlement of restricted stock units
or other equity-based awards granted under an equity incentive plan of the Company to cover tax obligations of the undersigned in connection with such vesting or settlement, provided, in each case, that any filing required under Section&nbsp;16(a)
of the Exchange Act shall clearly indicate in the footnotes thereto that such transfer or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit A </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
sale is to satisfy income tax obligations in connection with the vesting or settlement of equity-based awards; </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:12pt; font-family:Times New Roman"><U>provided</U> that in the case of any transfer or distribution pursuant to clause (B)&nbsp;or (C), each donee or distributee shall execute
and deliver to the Representatives a <FONT STYLE="white-space:nowrap">lock-up</FONT> letter in the form of this Letter Agreement; and <U>provided</U>, <U>further</U>, that in the case of any transfer pursuant to clause (B), (1) such transfer or
distribution shall not involve a disposition for value and (2)&nbsp;no filing by the undersigned or any party (donor, donee, transferor or transferee) under the Exchange Act, or other public announcement, shall be voluntarily made in connection with
any such transfer, and if the undersigned is required to file a report under the Exchange Act in connection with such transfer during the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period, the undersigned shall include a statement in such
report to the effect that the filing relates to a <I>bona fide</I> gift or that such transfer or other disposition of shares of Common Stock, as applicable, or any security convertible into Common Stock, is to an immediate family member, an entity
of which the undersigned and the immediate family of the undersigned are the legal and beneficial owner of all of the outstanding equity securities or similar interests, or a nominee or custodian of an immediately family member or such entity, and
not a disposition for value; and <U>provided</U>, <U>further</U>, that in the case of any transfer pursuant to clause (C), no filing by the undersigned or any party (transferor or transferee) under the Exchange Act, or other public announcement,
shall be voluntarily made in connection with any such transfer, and if the undersigned is required to file a report under the Exchange Act in connection with such transfer during the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period, the
undersigned shall include a statement in such report to the effect that the filing relates to a transfer or other disposition of shares of Common Stock, as applicable, or any security convertible into Common Stock, to such entity&#146;s limited or
general partners, members or stockholders or its affiliates or other entities controlled or managed by the undersigned; and <U>provided</U>, <U>further</U>, that in the case of any transfer pursuant to clause (D), no filing by the undersigned or any
party (donor, donee, transferor or transferee) under the Exchange Act, or other public announcement, shall be required or shall be made voluntarily in connection with such transfer (other than a filing on a Form 5 made after the expiration of the <FONT
STYLE="white-space:nowrap">Lock-up</FONT> Period referred to above); <U>provided</U>, <U>further</U>, that in the case of any transfer or distribution pursuant to clause (G), no filing by the undersigned or any party (transferor or transferee) under
the Exchange Act, or other public announcement, shall be voluntarily made in connection with any such transfer, and if the undersigned is required to file a report under the Exchange Act related thereto during the
<FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period, such report shall disclose that such transfer was as a result of the operation of law, or pursuant to an order of a court or regulatory agency or by will, other testamentary document or
intestate succession; and <U>provided</U>, <U>further</U>, that in the case of any transfer pursuant to clause (I), no filing by the undersigned under the Exchange Act, or other public announcement, shall be voluntarily made in connection with any
such transfer, and if the undersigned is required to file a report under the Exchange Act related thereto during the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period, such report shall disclose that such transfer was a result of the repurchase
of the Common Stock or such other securities by the Company pursuant to equity award agreements or other contractual arrangements in connection with the termination of the undersigned&#146;s employment or service with the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:12pt; font-family:Times New Roman">In furtherance of the foregoing, the Company, and any duly appointed transfer agent for the registration or transfer of the securities
described herein, are hereby authorized to decline to make any transfer of securities if such transfer would constitute a violation or breach of this Letter Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit A </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:12pt; font-family:Times New Roman">The undersigned hereby represents and warrants that the undersigned has full power and
authority to enter into this Letter Agreement. All authority herein conferred or agreed to be conferred and any obligations of the undersigned shall be binding upon the successors, assigns, heirs or personal representatives of the undersigned. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:12pt; font-family:Times New Roman">The undersigned acknowledges and agrees that the Underwriters have not provided any recommendation or investment advice nor have the
Underwriters solicited any action from the undersigned with respect to the Public Offering of the Securities and the undersigned has consulted their own legal, accounting, financial, regulatory and tax advisors to the extent deemed appropriate. The
undersigned further acknowledges and agrees that, although the Representatives may be required or choose to provide certain Regulation Best Interest and Form CRS disclosures to you in connection with the Public Offering, the Representatives and the
other Underwriters are not making a recommendation to you to enter into this Letter Agreement, and nothing set forth in such disclosures is intended to suggest that the Representatives or any Underwriter is making such a recommendation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:12pt; font-family:Times New Roman">The undersigned understands that, (i)&nbsp;if prior to signing the Underwriting Agreement, the Company notifies the Underwriters in writing
that it does not intend to proceed with the Public Offering, (ii)&nbsp;if the Underwriting Agreement (other than the provisions thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the Common Stock
to be sold thereunder, or (iii)&nbsp;if the Underwriting Agreement is not executed by October&nbsp;31, 2020, the undersigned shall be released from all obligations under this Letter Agreement. The undersigned understands that the Underwriters are
entering into the Underwriting Agreement and proceeding with the Public Offering in reliance upon this Letter Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit A </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:12pt; font-family:Times New Roman">This Letter Agreement and any claim, controversy or dispute arising under or related to this
Letter Agreement shall be governed by and construed in accordance with the laws of the State of New York. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="96%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-size:12pt">Very truly yours,</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-size:12pt">[NAME OF STOCKHOLDER]</FONT></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="96%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:12pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit A </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>d79628dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g79628g43n25.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center">601 Lexington Avenue</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center">New York, NY
10022</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center">United States</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center">+1 212 446 4800</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center">www.kirkland.com</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center">Facsimile:</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center">+1 212 446 4900</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;September&nbsp;21, 2020 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Chewy, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">1855 Griffin Road, Suite <FONT
STYLE="white-space:nowrap">B-428</FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Dania Beach, Florida 33004 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:6%; font-size:12pt; font-family:Times New Roman">We have examined the
Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (as amended or supplemented, &#147;<B>Registration Statement</B>&#148;) filed with the Securities and Exchange Commission (&#147;<B>Commission</B>&#148;) on
September&nbsp;16, 2020 under the Securities Act of 1933, as amended (&#147;<B>Act</B>&#148;), by Chewy, Inc. (&#147;<B>Company</B>&#148;). The Registration Statement relates to the offer and sale from time to time, pursuant to Rule 415 of the
General Rules and Regulations promulgated under the Act, of an unspecified amount of: (a)&nbsp;shares of Class&nbsp;A common stock, par value $0.01 per share, of the Company (&#147;<B>Class</B><B></B><B>&nbsp;A </B><B>Common Stock</B>&#148;); (b)
shares of preferred stock, par value $0.01 per share, of the Company (&#147;<B>Preferred Stock</B>&#148;); (c) depositary shares representing a fraction of or multiple shares of Preferred Stock evidenced by depositary receipts of the Company
(&#147;<B>Depositary Shares</B>&#148;); (d) warrants to purchase Class&nbsp;A Common Stock, Preferred Stock, Depositary Shares, or any combination of those securities (&#147;<B>Warrants</B>&#148;); (e) contracts obligating holders to purchase from
the Company, and/or the Company to sell to the holders, a certain amount of Class&nbsp;A Common Stock or Preferred Stock at a future date or dates (&#147;<B>Purchase Contracts</B>&#148;); and (f)&nbsp;units consisting of one or more shares of
Class&nbsp;A Common Stock, Preferred Stock, Depositary Shares, Warrants, Purchase Contracts or any combination of such securities (&#147;<B>Units</B>&#148; and, together with the Class&nbsp;A Common Stock, the Preferred Stock, the Depositary Shares,
the Warrants and the Purchase Contracts, the &#147;<B>Securities</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:6%; font-size:12pt; font-family:Times New Roman">Pursuant to the Registration Statement, the Company has
proposed to issue and sell 5,100,000 shares of Class&nbsp;A Common Stock (the &#147;<B>Firm</B> <B>Shares</B>&#148;) and up to an additional 765,000 shares of Class&nbsp;A Common Stock (the &#147;<B>Option Shares</B>&#148; and, together with the
Firm Shares, the &#147;<B>Shares</B>&#148;) to cover the exercise of the underwriter&#146;s option to purchase additional shares of Class&nbsp;A Common Stock), all of which are proposed to be sold to the Underwriter (as defined below) pursuant to
that certain Underwriting Agreement, dated as of September&nbsp;16, 2020 (the &#147;<B>Underwriting Agreement</B>&#148;), between the Company and Morgan Stanley&nbsp;&amp; Co. LLC (the &#147;<B>Underwriter</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:6%; font-size:12pt; font-family:Times New Roman">In connection with this opinion and the registration, issuance and sale of the Shares, we have examined originals, or copies certified or
otherwise identified to our satisfaction, of such documents, corporate records and other instruments as we </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">

<TR>

<TD WIDTH="100%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" ALIGN="center">Beijing&nbsp;&nbsp;&nbsp;&nbsp;Boston&nbsp;&nbsp;&nbsp;&nbsp;Chicago&nbsp;&nbsp;&nbsp;&nbsp;Dallas&nbsp;&nbsp;&nbsp;&nbsp;Hong&nbsp;Kong&nbsp;&nbsp;&nbsp;&nbsp;Houston&nbsp;&nbsp;&nbsp;&nbsp;London&nbsp;&nbsp;&nbsp;
&nbsp;Los&nbsp;Angeles&nbsp;&nbsp;&nbsp;&nbsp;Munich&nbsp;&nbsp;&nbsp;&nbsp;Palo&nbsp;Alto&nbsp;&nbsp;&nbsp;&nbsp;Paris&nbsp;&nbsp;&nbsp;&nbsp;San&nbsp;Francisco&nbsp;&nbsp;&nbsp;&nbsp;Shanghai&nbsp;&nbsp;&nbsp;&nbsp;Washington,&nbsp;
D.C.</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g79628g07x00.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Chewy, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">September 21,
2020 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Page 2 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">
have deemed necessary for the purposes of this opinion, including (i)&nbsp;the organizational documents of the Company, (ii)&nbsp;minutes and records of the corporate proceedings of the Company
with respect to the registration of the Securities and the issuance and sale of the Shares, (iii)&nbsp;the Registration Statement and the exhibits thereto, (iv)&nbsp;the base prospectus, dated September&nbsp;16, 2020, filed with the Registration
Statement relating to the offering of the Shares, (v)&nbsp;the preliminary prospectus supplement, dated September&nbsp;16, 2020, in the form filed with the Commission pursuant to Rule 424(b) of the Securities Act relating to the offering of the
Shares (the &#147;<B>Preliminary Prospectus Supplement</B>&#148;), (vi)&nbsp;the final prospectus supplement, dated September&nbsp;16, 2020, in the form filed with the Commission pursuant to Rule 424(b) of the Securities Act relating to the offering
of the Shares (the &#147;<B>Final Prospectus Supplement</B>&#148; and, together with the Preliminary Prospectus Supplement, the &#147;<B>Prospectus Supplement</B>&#148;) and (vii)&nbsp;the Underwriting Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:6%; font-size:12pt; font-family:Times New Roman">For purposes of this opinion, we have assumed the authenticity of all documents submitted to us as originals, the conformity to the originals
of all documents submitted to us as copies and the authenticity of the originals of all documents submitted to us as copies. We have also assumed the legal capacity of all natural persons, the genuineness of the signatures of persons signing all
documents in connection with which this opinion is rendered, the authority of such persons signing on behalf of the parties thereto other than the Company and the due authorization, execution and delivery of all documents by the parties thereto
other than the Company. We have not independently established or verified any facts relevant to the opinions expressed herein, but have relied upon statements and representations of the officers and other representatives of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:6%; font-size:12pt; font-family:Times New Roman">Based upon and subject to the foregoing qualifications, assumptions and limitations and the further limitations set forth herein, we are of
the opinion that the Shares are duly authorized, and when the Shares are registered by the Company&#146;s transfer agent and delivered against payment of the agreed consideration therefor, all in accordance with the Underwriting Agreement, the
Shares will be validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:6%; font-size:12pt; font-family:Times New Roman">Our advice on every legal issue
addressed in this letter is based exclusively on the federal securities laws of the United States and the General Corporation Law of the State of Delaware (including the applicable provisions of the Delaware constitution and reported judicial
decisions interpreting these laws), in each case as currently in effect, and represents our opinion as to how that issue would be resolved were it to be considered by the highest court in the jurisdiction which enacted such law. The manner in which
any particular issue relating to the opinions would be treated in any actual court case would depend in part on facts and circumstances particular to the case and would also depend on how the court involved chose to exercise the wide discretionary
authority generally available to it. This letter is not intended to guarantee the outcome of any legal dispute which may arise in the future. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g79628g07x00.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Chewy, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">September 21,
2020 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Page 3 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:6%; font-size:12pt; font-family:Times New Roman">We do not find it necessary for the purposes of this opinion, and accordingly we do not
purport to cover herein, the application of the securities or &#147;Blue Sky&#148; laws of the various states to the sale of the Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:6%; font-size:12pt; font-family:Times New Roman">This opinion is limited to the specific issues addressed herein, and no opinion may be inferred or implied beyond that expressly stated
herein. We assume no obligation to revise or supplement this opinion should the present federal securities laws of the United States or the General Corporation Law of the State of Delaware be changed by legislative action, judicial decision or
otherwise after the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:6%; font-size:12pt; font-family:Times New Roman">This opinion is furnished to you in connection with the filing of the Registration Statement, and is not
to be used, circulated, quoted or otherwise relied upon or otherwise referred to by any other person for any other purpose. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:6%; font-size:12pt; font-family:Times New Roman">This opinion
is being furnished in accordance with the requirements of Item 601 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> promulgated under the Act, and no opinion is expressed herein as to any matter pertaining to the contents of the
Registration Statement, other than as to the specific issues addressed herein, and no opinion may be inferred or implied beyond that expressly stated herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:6%; font-size:12pt; font-family:Times New Roman">We hereby consent to the filing of this opinion with the Commission as Exhibit 5.1 to the Company&#146;s Current Report on Form <FONT
STYLE="white-space:nowrap">8-K</FONT> and its incorporation into the Registration Statement. We also consent to the reference to our firm under the heading &#147;Legal Matters&#148; in the Prospectus Supplement constituting part of the Registration
Statement. In giving this consent, we do not thereby admit that we are in the category of persons whose consent is required under Section&nbsp;7 of the Act or the rules and regulations of the Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:12pt; font-family:Times New Roman">Very truly yours, </P>
<P STYLE="margin-top:30pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:12pt; font-family:Times New Roman">/<I>s</I>/ <I>KIRKLAND&nbsp;&amp; ELLIS LLP</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:12pt; font-family:Times New Roman">KIRKLAND&nbsp;&amp; ELLIS LLP </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>chwy-20200916.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-5 Build:20200707.2 -->
<!-- Creation date: 9/21/2020 11:16:31 PM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2019-01-31"
  xmlns:chwy="http://www.chewy.com/20200916"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.chewy.com/20200916"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="chwy-20200916_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="chwy-20200916_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.chewy.com//20200916/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>chwy-20200916_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-5 Build:20200707.2 -->
<!-- Creation date: 9/21/2020 11:16:31 PM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>chwy-20200916_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-5 Build:20200707.2 -->
<!-- Creation date: 9/21/2020 11:16:31 PM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.chewy.com//20200916/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="chwy-20200916.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.chewy.com//20200916/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g79628g07x00.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g79628g07x00.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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<+7 [8H !%& 0(U /48H < %    '84 +0!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g79628g43n25.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g79628g43n25.jpg
M_]C_X  02D9)1@ !  $ 8 !@  #__@ ?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$  @&!@<&!0@'!P<*"0@*#18.#0P,#1L3%! 6(!PB(1\<
M'QXC*#,K(R8P)AX?+#TM,#4V.3HY(BL_0SXX0S,X.3<!"0H*#0L-&@X.&C<D
M'R0W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W
M-S<W-S<W-__$ :(   $% 0$! 0$!           ! @,$!08'" D*"P$  P$!
M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M,20?GP'^7C[PZ9[T 0:!\,G?X2CP=XB$(G1Y'CGMV+^6Q8LKC('(SC'IGUH
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M:-(V/0_]- /P- %9?'=AYFF1O;S*U_<S6Z\K^[,<AC!;GHS@ ?[P]Z *LGQ
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MAU[5+FTM[22%;=06\]U249 ()B^\ <\'IQ0!T5 !0 4 % !0 4 % !0 4 %
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MZAW!!(@$(SQ_= _'F@"Q'X>MUUY=8FN;BXN8U=(1*5VPJY!8+@ D<#[Q..U
M&O0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
74 % !0 4 % !0 4 % !0 4 % !0!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>d79628d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="chwy-20200916.xsd" xlink:type="simple"/>
    <context id="duration_2020-09-16_to_2020-09-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766502</identifier>
        </entity>
        <period>
            <startDate>2020-09-16</startDate>
            <endDate>2020-09-16</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2020-09-16_to_2020-09-16">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2020-09-16_to_2020-09-16"
      id="Hidden_dei_EntityCentralIndexKey">0001766502</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2020-09-16_to_2020-09-16">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2020-09-16_to_2020-09-16">2020-09-16</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2020-09-16_to_2020-09-16">CHEWY, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2020-09-16_to_2020-09-16">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2020-09-16_to_2020-09-16">001-38936</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2020-09-16_to_2020-09-16">90-1020167</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2020-09-16_to_2020-09-16">1855 Griffin Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2020-09-16_to_2020-09-16">Suite B-428</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2020-09-16_to_2020-09-16">Dania Beach</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2020-09-16_to_2020-09-16">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2020-09-16_to_2020-09-16">33004</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2020-09-16_to_2020-09-16">(786)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2020-09-16_to_2020-09-16">320-7111</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2020-09-16_to_2020-09-16">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2020-09-16_to_2020-09-16">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2020-09-16_to_2020-09-16">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2020-09-16_to_2020-09-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2020-09-16_to_2020-09-16">Class&#160;A Common Stock, $0.01 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2020-09-16_to_2020-09-16">CHWY</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2020-09-16_to_2020-09-16">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2020-09-16_to_2020-09-16">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140475584222360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Sep. 16, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001766502<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 16,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CHEWY, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38936<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">90-1020167<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1855 Griffin Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite B-428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dania Beach<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(786)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">320-7111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Class&#160;A Common Stock, $0.01 Par Value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CHWY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MN X7S35GL W< '@?*V7?.^Y.7/Y+8_0/4$L#!!0    ( *^%-5&#J:4#U $
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M              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%
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M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( *^%-5$D'INBK0   /@!   :
M          "  ><0  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( *^%-5%ED'F2&0$  ,\#   3              "  <P1  !;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  !83

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d79628d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chewy.com//20200916/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d79628d8k.htm">d79628d8k.htm</File>
    <File>chwy-20200916.xsd</File>
    <File>chwy-20200916_lab.xml</File>
    <File>chwy-20200916_pre.xml</File>
    <File>d79628dex11.htm</File>
    <File>d79628dex51.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d79628d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d79628d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "chwy-20200916_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "chwy-20200916_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "chwy-20200916.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "chwy",
   "nsuri": "http://www.chewy.com/20200916",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d79628d8k.htm",
      "contextRef": "duration_2020-09-16_to_2020-09-16",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.chewy.com//20200916/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d79628d8k.htm",
      "contextRef": "duration_2020-09-16_to_2020-09-16",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.chewy.com//20200916/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.chewy.com//20200916/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.chewy.com//20200916/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.chewy.com//20200916/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.chewy.com//20200916/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.chewy.com//20200916/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.chewy.com//20200916/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.chewy.com//20200916/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.chewy.com//20200916/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.chewy.com//20200916/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.chewy.com//20200916/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.chewy.com//20200916/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.chewy.com//20200916/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.chewy.com//20200916/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.chewy.com//20200916/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.chewy.com//20200916/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.chewy.com//20200916/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.chewy.com//20200916/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.chewy.com//20200916/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.chewy.com//20200916/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.chewy.com//20200916/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.chewy.com//20200916/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.chewy.com//20200916/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-20-250245-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-20-250245-xbrl.zip
M4$L#!!0    ( *^%-5&)5V'^8 ,  !X,   1    8VAW>2TR,#(P,#DQ-BYX
M<V2]5EUOTSP4OD?B/QQRQ2N1N.FT38W6(6!,FC0&*@-QAUS';2T<.Z_MK.N_
MY]A)VK1K2[<A=C/7YSSG/.?3.7M[7TBXX\8*K891FO0BX(KI7*CI,*IL3"T3
M(GI[_O+%V:LXAHO+JQN(8>9<:3-"YO-YDD^$LEI6#BW8A.F"0!RW^A]NO\'W
MVGH&(RXYM1SZO7XO/H;WE9!YYG_T3GNG2;\+,YQZ>Y!3QS,8D'Y*O"*D:9:>
M9$<I?/D$'ZEUW"BX%07O8G6Y,&(Z<_":_1=\P856BDO)%W I%%5,4 E?6\IO
MX$JQ!-Y)"2,/L\C3<G/'\Z2Q>F_SS+(9+^C+%P"8,&4SA2:K8ACY3#2)N!\;
MF6@S);DSQ"U*3E I1BUN!(LZT#_C'F"P$EYBE\ )M>, :B68GW00]]+X*.W@
MV&R^6'.&8<P7H4HA\8/TI*.=<[%4#JPL9\E4WQ$4;+?OM<3V:-#Z$<'6<)AP
MWH%(H7[M07CQ&+NDZ^0!9'X4 .E@,"!!ND$I=^MQ--:/22WL:%O!MH>, A]R
MV@F9.F?$N'+\4IOB@D]H)=%/I?ZOJ!03P?.@A4U><.76=-8U'#53[FYHP6U)
M&3^\/MB(V]* >BGY\>GZ:^C1Z-P# $+;BJ+4QD'=O=>:A:G:DWW_*VZ+%ONK
M..UC_ D:BT!MI;RCXD">3:3MA2<163;2P43LKK;WAWC5_[LX[!N9)V=C<RGX
M7 Q\+M*3@W+Q8*G\!29:W3R73&<S/H;0UA'UAW@UJP>59V.\G]XCB@H6EN]I
M??1$3A]!9(5_;J=T%IROR_%>]YL;L?$:?%*EM N.NDQH60HUT<T57OH!R]HI
M&_$)A$V<4<.,EGS_OB:ET24W3N##M1K4VL#,\,DP\B]7W.[ GY*.$]R!K<H#
M!^NC[\4$(5Q>K^BU6"><!U][,7@Y?@%0N33MVW,86<R[[*R.?QQN:?ACPT6(
MQ6<GE&UWU%\Z6H\.WONY10WPAV^CJQT/U_+E(H[>:Z6+1<WP0K/*OXSM_W<J
M_ZB0U^(*V\H4@5,$ I^X$:K_/$A]R;#EF'/\'!6A=].>_\.OU=9"]TA5#K4Y
MZ-@[(YM&-NU7EN>?U7DX,RI9)9<9;\"-QC[@9JT.1ZZ8[<8UMVVUVADFFT/<
MW'2'O;ZJEPW^_ U02P,$%     @ KX4U46%HGWZ#!@  2D<  !4   !C:'=Y
M+3(P,C P.3$V7VQA8BYX;6S-G&]OVS80QM\/Z'>X>6\VH+(M!UL1HVF1.<D0
M+&V"QMV&#4,A2XQ#3"8-4H[M;S]2?QHYIF0J.E9YT5:1[IZ[1_F=RDARWK[?
M+&)X($)2SDYZ?G_8 \)"'E$V/^FMI!?(D-(>R"1@41!S1DYZ6R)[[]^]^N[M
M]YX'9Q>7'\&#^R19RO%@L%ZO^]$=99+'JT1)RG[(%P/PO")^,OT,?V3EQO")
MQ"20!$;#T=#[&7Y=T3@:ZR^&;X9O^J-RFB"!UH,H2,@8C@<C?Z #P??'_B_C
M(Q]N/L!Y(!,B&$SI@I1S^7(KZ/P^@1_#G]):<,89(W%,MG!!6<!"&L1P6[3\
M&BY9V(?3.(9/.DVJ/B41#R3JYZHQ9?^-]5\SW3V\^@Y G48FTWTG/7TR\G.Q
MF8FXS\5<-3L\&A0IO<>,S5[*^BA-\(^/CP?IT7*TI*98)>X/_OIP=1O>DT7@
MJ=.OOEUA7D;2L4SW7_$P/8<6#4)EA/[**\(\O<OS1]Z1W]_(J/=.%\S/3C C
M\97:@M3#6/"8U!36A]/JO3P^V2Y5/-DDA$4D5_ZJS<,\ZEZ0NTQ5PY=*2A+V
MY_QA$!&JI/UCO>'I#6_HYWW^H'9]F7!%_>E,)B((D]VJL3Y17!0[4RLG/4/2
M8+<M'7<JPAVM0(2%CMH\<!;RB$'(U7=OF7BI8I%^)_C"V$5>CAL.?HEGL;%-
MS9/:TD-.F/?Y]I#73*AL3!#)5T)!UN0;G/IYERK#/X7VOV\'C[5?2JOJ0B+)
M5=-^,< \72CDU9_D(@[FMF ^2>H(3'/KW'"P#9@&(20PORJ#EFZ-I8-&RUC:
M=HL!Y3E+:+*=J&(BB"_5)7GS.]G:PEF1W!&D]59X35 ;:&L$D>#-*D!> M(:
MH(JTQMAAZV6<F_>/ ?89#U=ZAJ;*@RW/NSD=86QLG.\?:P/MO@X2JX4P:.76
M@.*W6>;2LE=,&&^(H#PZ9]&9^FFG*95/DCO&TVR%UP1A &L0Q"8W*P&J!N@B
M:! [:-U(LW7_>,N'3V1.]1*:)1^#A377YMQ.%P\51GAU3/NE@TD/=^7P6 %T
M":1U@XN^#<L&Z^;Q<+YD(1=++M*;*K>)&J()7ZG%RW;"HX9T'Y#J%'8[F]PZ
MI?TH6,CC3L9.04@K0EX2=$VD4?D&O@R3\WQS>*-T06/R<;68$=%L;LIYG0Z)
MP0 W'V^/_U,M7-:U.F3R2%AC]VM@V*II/%RGP>8R4HLH>D>S6^K/8;=2I%.0
M#UGC%L'M$:\5QN5=E8+=6KCT.[5B&(5G^,$;C-,H4C9D_L\59<1O-A1&@4X'
MHLX2/Q#8?A J17&'(-=_76R K@37#&MEX\R&80">X<7E (S:#L#HQ0W R'8
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MUDMYQY7:TK\")M]%LU^$HO;\#U!+ P04    " "OA351=P^Z=L8$  #*+
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M1S)@O*RO"7U=V"G[[>/3W;2[G]U_VK7D2^JJGI!#Z@/EX$PG!:-<*-=2DQ2
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MLN// $0!T5$3I+_L7.\F8*5+CT\_[!S%^$^@?-Z;Y*X?W.E5BXC>HSL2>=+
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M9<PM>11]X)!IUF(2%2]QX(V#91N@ %4H*8" D8_B(XN9!<04'+ZGR28YJ40
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MA7U,'R8SL"@K]#L]_O5==/KR_P->=^<''9(\6@__XV?ZOQ^B/UX^>__KWWX
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M]UY5ZNM'&/X<JK5P5W0&6#0Y6K8A)G+H,[PK[+UST"*=S!61WOE^R)WZ9OU
M/WWW WU& OTPE$!=1B0*$6<]<M7W^[#W4[_QUV7C(2321Y 1>-4%^9(CQ&S:
M#C-B^2H$'X6N)ENU+:]C'N_AYYO5#5^?>\R&'@ZR"D62E0,)43Z-[EBA_=P0
M![[!FA.( L%I)&*[-8GD=)G!N\'\@V8RF@2E-;S\FI:T]0^$\G2S5MHO3H-T
MLK:5H"5_J)+=L&'WR'UF%:_:'U-6=6G@"R1FTFO;BO4V$.C\"@'T?V;%S'DE
MGZ739#FK!3/LBH&L# [*^0/@I"[\R/PT:)]ES<&<C=0R6MU"9VZ'_=+P3[FD
MQ4<F,IQAB@PMQ54I$>P9<9]B+"%#C'H)/*Y6@&%KB86@H G$-AS3>2RJD<=H
MD-XL[C584<R$NPS=?Q2)K-+RPJKU&(&/*5"6)YQ8[WV9034RYQX@&2P)J@+L
M\C/*VIQ@:CW.$H%RXVA6$(:I,EFGD 8?>8,J[!VRV?0A5W?$B*^X)2O_ZR')
M ]26I%ARTH![-=\D[[<FWVN/C=,SJ-S+1X+*T$=\''.\)"H";F&BC'\N)V?,
M.RC.&%,JCP%1-0-HQ!%A=/M"CB'\:COBV+93"#.C,J3+P63X,TI&!?;&GEKS
M3,@-W^-7:)(8!NKNVZ^AYU=@82<"\F"D+!4'QIZKDX050&O/WF,)[:#>P3X-
MUT/#J#I=7GS\>KT-VTJQDNM3:]D,/=[HWM;.&Y5@3K6<^W[0^-EF8%S)T:-1
M'$#(S7G7G:_;L?P0:X-N@L^;0=5^?![2K5PL71$C.I=A'Q4XPSE5DG)^1PH:
M"HH13N<Q-JV68G6PE%8XAU%OPKR(6)BPLG?'V5FQC<UB=++8A8NB9O-BXF)H
M]-;Q.)VE&NN;QM?DXO WR*0<<8DHT'<37+V1#-+/U@<RX&ZN+OL]Z"0V<W>;
M\F5("GX7D)*\T;3@H;OC=(X!'I^&TK$W0.O8O\*20B&U9BE7D%><%;-&;J&W
M4E)E DF%F$]C/O9B0AXWO/QAT/RBH?VM7YL_^:SL#*MZ*=B$R?!BL"D%XVO&
M[W9WNF3:5PV5%5<3:9R'_4[JHAV,[YB_48 RQ(-78Y".G;*>)&EJRFE7!%D;
MAU@%\'D0^_==(GX_.#V(AM!,+/<>*:2_M'Y0Q )M0WROWKQAKV>:W=VY,:+]
M5GUQ#[[[XFZRMJXS)<1B2VJ1S# MTZE/7M&,ANJ9'4JB<?#;[/#@>E-.D)E!
M+Y@(S5A"1<1P/%^I&HRE$ID#_V6.4H4LI6KQ%(HI2*=(MW>R0%]R]C*?@/(#
M6_'.&T['WG!ZF8\/M SHQ<O7[XY='5"N&#*)0?;E&L PN/5T!C;YZ8<5IX?U
MM+OQ?:\)]"),;#=;*?,/&RP;\ZW26IC/D(?0T"#4*F0XQ)L_/9L !IL@NF$1
M%2.JT+Q!BY-+ ?BK&36YD\8:D6G X<R@E V6?A.(SLC>FBV0_HNATO\5-GG!
M0Q=0':G$?*[93+9-\LTGN@2!*^DWL\;#$;1P09H;RS\F*2Q[ O_0N&2US(@^
MQ7?"3V4Y<@6YIAY'R-7]'?-P<N6!,RN:T2>YKQPM#S87UXPKF5SL'G:.F/@&
M Z9DNUQ_U/59E#>1JNAS3@,WA;7M!WLKV Q=D_-VK10@=WG:/3UO\NYLTH5S
MZ<DC9,W=EBWTU.Y.J/"*&,Q,CD&E]29!$91<6')L\XGH5=%W$6WB8TX2]RH%
MV@!Z>&[FNITJRL9&^:E0:*5 K]N-O*H+_4#,:\T3'("M4FLD3&S0KGT6JYQE
MJ!9\J@N)4H-,4HA_:>L,I,EM_R$(,@@B^E!6J,NBZX<H_6+G]DF3<_&2+3CJ
M;?!W_WLX?)!OH';,5=^)PP]ZELX*!,"1WU CVO<%L)P4V]!B7%C$PACM&TSC
M!]T1_HGJ7"?,PZ!$>!BU0II&H %40 ETL: F=U^P_ILBR;H^&_ 6), 9J#/8
M(\W!EA/<5Y:'H(3W]]+]2)O[(*W;AG6L,-.PTFDZ\2?0V?MP;7:S0<F>ITEN
ML0R[82:ZZ\R32;&HTP[D0K]+/%E7^WGLT0+>H$Y @"=/BZ2<;(&B7 [.KLCJ
M&56FO$M15B*$*35,9.V9E+J@#(H3BS=62)PI?ADLZT-:4[)DK:_"#!KCVM8B
M!U$<@;)FK'XEFO>7:;OECLO5P,\/Z/#.WM3385"GV)$?B'8@4XS/:ZU\G '3
M_];F#\8N!]!5@7RKKK"?O[O";M(5-DFGC$K3G5:ZB9Y(XM,(QK5?89$=H25Y
MB]^5.GN'C.JRRTJ:![.)N+">E<T2(FCJQCH5#Z9MO-7\ZPCP]@1P_#INHJ[H
M>6>5D@^<]OR0)62)G$^70*%2[!-!W 53?N$X%BX/;Z',T2WY/)VI%< !QB%[
M@#+1_)"RPS@<COE;8TXNI^$JB?/0/C/]J%-0E4AOFU+3A@%4T4D-P;E*2[=U
M6Q/YG2G*CHT9L _;H#-6PW7&.IVA9%JV9>/@(KG0RR?01TUOQ$:"CX-2I_6W
M[3+W5A3A-,%I5U([.($C1$^@%JN,"UH@*'TS:9XK36>ZEAZ]HU^I)QDFC605
M5"TMT"9'4N%_[.Z(DUDL/=!8T<-5?D#/5EI>8/*8_$E?17DRQPLP@:-"*&+^
M:UPL5C)A4>*,_Y7T"/,2MDY0_$L:  RP,9"&OH=;Y\5EK)&TJIC6E]3FJ%J!
MZBHROD['YWDQ*\Z"QDT\\PHCRK6 N+$RL,QY%SA_],?"?T*W'>\-G%A-23!D
M D\1(J9NPF:A[.!)[!M-([,GY*Z@H4%?;3HM6M7-'+@3K1L3,GV!Z<'F^D*B
M529YP5(7;!3%@X?I(\:X%NZHB>_S7&+2_0A@;1VI4?TQN6]B+>8.1O:CPC6;
M!DY%4O!@PZ?)!=A1N-^3=)P)$.,&Y)KMS_.JKQ 4_SWWH95WJ9@_Y]G"][@M
MS:<&]<55W,2,8E!A:[CZ4KH6)?.BIPM[9PV8H-ODB#R43WR6%K^AP!,NIE.@
M'_P7%7M@:33]-5["WW/^8DDP=J7Q$R53C,P0[-U@#[2?#P[A$6V:X;9F%Z4.
M%Y_ERVL Z#NL;GVIN(6"49O HOD W6T;Z'(Y7+9B!(2V1X\+-KA=W\S[(YUY
MNJMP25UU;0TV!).-J##93QA <9+CJA7V5_5WNQ3 $<4A/("_^DE(U=-ZY,QO
ME,!Y2$TRNT'8.F_X0;HW%[\]^OGN(2=,(CRY%#;T^TA:6'R\1Z3#;@.Y70QV
M>B0?4W'V/?<IQ<X[T$B7VJ2+U39_V^6T=J-473AO-)SZ-)T@P&?,[@S,7!R+
M%G_E7)\Z^0A'52_+/.C>Z;W?S,(0Y](#WILN+K&MSEA@7B8A@%/:;251244N
MY6H5].'@-F(M32H5,2N2K/HJV_60'O6^;X:ZIQB6(C:0QVB:< (59X=(?-%I
MJ2DJB;J-@I\JA3<=?>\0E7+?52[@!B'@Y#BC]"<# LI9J'@D?*ZS5=/ON";Y
M,Z9B#NJ49W_AH"N",!85+=AY9+HG;D6B&ZU72$:I49AZ^KSTB+IOMU3RZ/"[
M4^HS\L[+H;SS& M_DC%1EP>Z=E6] ?YG*TY\M6!$'RC',P-^ ;- >41B&*O4
M11S"E2BF22E05RM%<-8,&)>?3K%V7W8@Z?.B*TC9>S[IG8F3"<B+=W=>,$/'
M="O04",0,YR#^N]E2LCGTR%%6Z\;K/U747PWKTS5%-5C&EG<(2BT"!]B2)C2
M%2M:,>E6=,AU2KU&<(> C'HQ243I2&IJ/NQUI2 P^%6C(1\'IPV)DT #(2 &
MJUX4.&[XT@-%B5Y1_KUU/9C$,I]M-D7/[WE&#TA(<:P&3)XJ# Y;-_I[8O%!
M:AH^/:"**O-XX+(^EPHH'D7G*&CF!5(V/78$MU!4G4X#O>ZP^WEZ<\'T-?A4
MT\)F(1->W%G!N/K-LJYK9Q2UL^&]W^]S+E%[NPR3\$1_SA/CG3"2IN62PQJ-
MX,KTHO#%-V$QSA0I76KGA&@B+OO<G+)X!3\,&!T"]#+-<H',^237# Y%%?NY
MNL)8>YIEZ84TNV^MRYACNSMEFJ>7_DP;8+Q;P-A65W#\O"*\V&<,$.N]/6T8
MV1'[I15*UD4-,-VL6*57\:R(IRBBYH&;$KLPTV&.JG@N28";].#M=\S][V!@
M-\D?>9Y?9&6A+/PWEJFL7+G8WWN;1&6OM)I7+L5S6'&)3YZ+KVA-J(C@2JMV
M(M>$ O:4X84.!9\]K158E=9>88Q ;J!SY5'B;*N!"+ZL,[]O1>7CZH9O@VU)
M 2%L:"X%:+'BB@*/=1^)+4[J$R4;<(HW?XFE[6RD^]QZBSZU*&8S*4X0':SV
MG5#/ET 48&\G,Z[LK))I6J_:O=@=7P9:9^E M/Z_23DII!M1\1$[Q<))<$N=
M_9AUL-13#\T55K4L65,#CD4'$>Y0,]-F65&6>3[A8J<*5 ?*$X.)+[$/T+*D
MSRD3%;5.J=VLD8#XK>A<IM)2^B?,7S41J;Z<KE\)?G:95)05R)NI^%E4T8_E
MHM2^6E28\+J\ AI4;<;AO28]U$+IS+.JT)SFV")+:E3;2$OMBZ$HLNP@-JR)
MI KY&L :X3A.!6MRRME_@JT8'QX>LGRE<"QC@'!M[B0 Y>^^L\[-U$@Q)U01
M.TEN7^I](>U]LI1 JD'J8-9<1+CK5W@#!%'8)M1VY#>W?RW'"#HNN2>'$@*P
MLUY*T/Q2A])_-5T)A@!5;$':MJ*=H81!& EJPV(O=_<FBE7(M*V>/R[%7 =(
M,*1GPN[.$ GW33ISCKX[<SZCVI$DO7H'ZAI-YO#NY>EQ0\= <W=W1S4^H,L\
MG0+/6\R2/.Y)N6QDWMUQ1=W/=91W:2V27#TDIYIPYP(2/]T- A+*YW&*PMIC
MXQONN.;S=#ZBLEVZ[8+BBOGDF-LPB7XIB^5"6Q)I!R*V$5#K->CFPNBQZ,6/
MF7!N.H]UAF/1=?>PY'T)J<'NW#VZ&^V-]BD5:BP[[H(UI*#,8+,NTGR)R^-$
MJZ.?']P/M\;G9^ S;G?4>TX*B'80;Q[/X6W\C+:5W!B8CM"8XNTXNOOS3T?T
MOS_A_SXX?,;_>:X)#,3NI(&]=Q-4,@YO,@N#YO+W:NK/[C@U]OYSAL::;8-=
MBW'/X'_FO']%N'\XU+XP5N>%]QCX>SAEV*/='?&! $&KRN!B IAMXM&#FK*4
MK%_R$[IH68>*:O?#U3FH^ML97K,2>02:*QJA"N*/4"=T6.Z=O&7&^P&2S\RT
MX?9 S?C3B@LM,!2;'52M@'/S94F#6,/=P_N.]J(6V?W\T[V0*@*PJ:;.BCN-
M1X@;X?-O7)44<#":/*6:EUA?S+^2(RDXU2:9@#(ASIH+*C">*[#RS4("/;*:
MRE3O#\U?H_\F"D=^K*6@"1/!M._#;;M75.+6>\W9(L&5SI=S-S!!:H(6-F#L
M?@[2PMQQ-ZF"+:VHT<&>&F1U\@%?S!V1.(6>CO$RR01T@*+NN#L:?'1W"G.Q
ME3US4T+.@4+0-*-%A;$R,PG-(U^B<O?9IM0)FG\SU./:(Q7*P+A@A/@,@;.I
M:!MT$>_> 5;JCG$_O&M<>]*SK?044ZT W.%O"5 >A;/667X:_&W<L1G:N &6
M.*17E)?<_&VH!]"DM?D5AW);ZZVXL ">B1NRA"4;%U" 3NAXFHU[D[8@-?"N
MLHMN/!E:Z3Q;SOWG0EM/1=OZ99D@).X*S3[?]T2]]T]_.7$ROZ=;&.-",I$+
M$A-9QLI!2:&AV9@$1FV9,8>G,]$ 2]+\^'4#F?SAT5ZR+UJ@D)?AIQM('0S\
MBX8M?.+37>X_JKQIK*8PI08Y,Y;Z$C+-F=IJ3>1J*5FGG'W*/)*P6YYA8]9:
MH<;)=QJO/:3H).Q-0RHI$4(/_ H^H'UM?* &M#%^HE?4A?71GPM@6@ID+SHM
MZRG<H>*2\JXN2.E9SSAFV0?)JJ!GNOGC$!7ENHL!;5%#@*:4&TB^)*=4\T7(
MU9=\\.'];6364*Z\U#/AT52MVN^RH]I=/ 9<F+&[,\TJ="BNI S)_KPSO$AI
M7Z4/W/BY*@2)F3#-L('-WS4JWZIH7E2<Q9LCK#JIDREW]W1S#-QD5!;H-S%\
M-Z8%5<5,3SYD3;L[YUGIW6G:8"AKC8DSSY?*Q'4-/A2!MY1=."S"^2 8RW*U
M^<P';(K8-T"Y\R6[9L&DJF^5WIA5Z]CXP/K%,*'*F'+>J4%Q,26%IZ*85='1
MX?W]3:=NO6\W>MS?L(OI]G<7TV=T,8U&ZUQ,)K(M.I>F6PY.HU C'!D"6W%H
MG''I X[ U]*WS%;'C+;@+L;II-%^6MT],.@[1/K;F(IS=">Y=71O+]UO](&V
M':;W-5:)MK?4(W=Z!9H_Y'5+^I_+1JS@A"7ZDW/LARQ#4P#2$$(^F[\A?$C/
M0^- FYS6E I*+G38:8JU^;RFH&DVB6_,ID2MF+:RH@"%RP6:B/,"AQ>S7#$]
M$?!9&\:C\I(9RXOB%Y([K(J<]X50YR/K!>DYT=Y=(E88M)BO(LNWJ=X7)K#,
MI<55MVH)!)Y(20G;M5290XA)).N+2UKE;.5R%VSHQ1V/)\T#Y$!?.5-@/%YW
M7XW@T?MZQ>:7>EW17>HN*>ITHFG+63*RH"_D9A+"]W[*!9T.O:"KX=?3YSN'
M-W/$D(W^YE3+!5H/E>+4UEA,A?X(EQ@%U).CBC)3\+H+29AVGYO.BZ[JQ155
M5@HO1 X;@5*=+G-%B:H+S8/V"C*V5Y.NP88V>=VFP?.T\RC4QPCV*2@=KCJB
ML_Q^*EX1/.3='?$W5WWYV .JR1S?=Z23>.)T'*%:3CF'NMZT?.%^'NK'HBAA
M_-1US.B8LV<%RAS .*.T262BS-W&P,AM)EX0QVV^3-DJ<I:@ 21G/S2WO(,[
M=9X"*]]$(_7*;S>?9&%DJ2!MR/E/Q4!19%D+BS<>4WOL3@[IT!PQTT1K!8J<
MBHVOMX=A,J-$==7!PV2K&]=>PKH9>LV9)N/[[_(#26V)ADB.TBNECM1Q?FG9
MGDGK[]V=+O-\DDT%F$7BTKH &C=A9C!)ZH2J3?Z'7(GXVJ?:P/:=NX*O@ TM
M,2&0I:%8U9^& ],H-UN;ARBYP NLN6#0I129N1>M8"#,!,2SMU<ANV:%IKLO
M6!W4$[5U@K-EAB@T>6H=S.SQJ8N#Z#03!"+0 R8]%\98.>P6:AJT[#]R.MA>
M9IRL;E&7H/C3&87FE;[D"G*NT>@=1= $:4Q\V4&81<31I[[3*9DM>,B4';:!
MOP9Q3M1AT_I!_$DSV8:<O,EDG2;T,A>YX=L@7*V!L0(>X77RU3F,,#HK*DTN
M+[/J@ZODY#8H9-)7VIU;W]K.,6))XLJB6/[5BO6Y'G>";WY?L3<[_=;YT_L2
MCO<\('N8>3PMBSFG#_.6$-VCB],[+_0+5M,D"\="3?@LHR W)\#AP]MDY:FZ
MY[)<<+RY\@.(<)F:UVIWF;T #[8G63BK;7IPQ*P("S5S("_<%B==W-B8+ ]W
M@5*[%5TKS=55)]_ JC+I@.B!8571\[\/1-48N1INKGM0MM'B!0<[XE9O.TCW
M,N]MN*EINC:-935"%R\GD#S"YL$)"CE)N'3Y+'L?]Z/WPT((3@0@YW=84-QT
M(_;-!6+L14AID<O<-M5DC0EM@XI[KS+-H@("YY11&D8LR9":5!;;JH7&_,(K
M]\WZX>Y\]\/=))A4AQ_7ZF4&E$3<'9C$[S!#8N )]65!&"OG8!4*JHG#-R'M
MU**9G(O&VH428I 8G$/>@#+ E0%F792B3>>$)UU.P&8@#&$:UJ3:,&XM!NG2
M\V0VE3?.]QM 0Q9U)<2K$:R:]]&I 6E!MJ )/AQK& \(0+(FMC+VQS $%.$>
MC H9<=>:B7Z]N].J!N9^:H7M7#8D,=1C6TF?XI!7=?(>MN3@ #LVR$7D!DWK
MDUJ(V#RBCC#@)X3XAIU2AD&.N8/AL02(KL&T'+.V&XA:=CI01CHZ':K8>B,9
M8F*:@KV&X9J:K ;GNYY8Y2SS .W] #]JG:%2?<8E!B*Z*55Z(3V1,!HZ6>9H
M2_%Z'1$4W.RXXYQ1,DE.6PN['^;65 2-.V"S9DEE)VPNLA^@F3>'<PJ+"67O
M)#V.N00\9(I#UB;,*;6Z/B?7:2GG3!<]6V&;#$",($0FMM:$B5!!3B"H[#'+
M+I*.\Z"D@X[S$/],NU:$%,2N7Y#*%^@=I&VP\A%'<-6]VZ*CF*\W-RE(8R=H
M<I_#GNWW91I@ML*5^N%]51_X=+I.GR1L)*#*Z7(6O4U61(%:)=<J*J *N:$=
M<8S(=/A&#*&OOMY\4($<7;XS\NBHO(T]X)'G^NPV1A=7,2;/@FLFASXHS-9I
M"-E!&$GGB6U-2IR$;Y\V0,:<PLI5XBYU+VU60!R=95.</MXZY)!AHTWW&[+S
M" XYJ*T"443%5[B7I/1[6:)PAF*.HZ>)L!^GP!M@:-\W-))^,TXG;Q12*U=Q
MN%><F$)_N/DMF#X(:%^"_^(#U(P>0@698^K1V' B/O*,&9(_0Z]OM0K<;C$"
MKI2]2/(:2@W7A2%1&.6@MBVRN>RQ'JQ2QEBS)7@_>$I@>B=C]:F2*H8(7THF
M7=75?EQW-JX_A/S#K'<,3"PCS!E\@?\)7X,@.99M+9=+U-6*U.$;Z*Q>R,Z?
M%&6Y! [WECRN8T%_YN*"GVP&O9M]H\2]H.B-ZP#G- ;5A]\\/WF&83)4DNC]
M^,[YB GU*5:!,Z"$3DB H]_(5M!R7@9GY1S [TV\0*!@YN)>%\JE+HTN]J1O
MPQ7>/CPZ;$ ]_ -F!%08IJ.9U6+Y$]A2,F-LRHH?C'D#<6FP'=(6]L+<LYCO
M$->+EBG^%_TP#.4SY X:[D!O[^  <JW,W8@[:CICJ>T><<UFLH*)X4^F,T+<
MT'L:1Q^R\8=1,O[0\2:ZX7/&3.RXV$,!$#-%%9G$4:#_":1K+-F8W*6;/3%!
M:,8_&NHB/8%OY%]%G<KO) -BK<85G#8!4W8<=W70V[*Z WH=7D#J!_-'U0ST
M+U<$RX!J0IL.FRV$9%O+J_48C3$#G\6=S)O>Z8]1 .+@"RS+I-^0/Q(S%LZB
M=,8:ST4"%!.[UN3,)KO83G,_6[OWS?II[G[WTWQ&W?/L["HE><=(6K\AO4:O
M$F+W9&6\HKZJ@K3D3<%!'28X:!#D- B."PJ7F@'=:-I=MING>AO5P5C>AS1=
M:-* CSAU95><4,JK6$<J'*W$,_%/+[()H!!NK,IL2J6DG9FYG?$VI-B^MIFE
M-*CN-B%K!V#HG%1:@%_XOK5F^0)D$)BAI0E3<B-#$HU25I1*>$*8.SFZVB &
MG/3=1F#6.H\F,03%[H)QIT58V"5,"KFE@%V<:WP10Z.Y8QJQJ9(OI+6MJDK>
MQ,[RBV)VH4K1NI3G+J2!SO50M)@S^-' &F 2>>R*+; OS\\WV)>NQSIOR:F#
M!\#%4Y88/G:E"O:KVIK;:6JV.FJCF';3'(%FN1XWQMA&=+N,NX*O'ME+4F07
M:_+];"4)7()-Q"I/C>@5SA7J(1S6W6=7-F),O;T-FBM=;C(*4FLM''-BRHE&
MTJ=]-2GX\7MT4RY!G9.BH#<OCK4H2)?3\4O*#)'8\Z8IBLXIKLG*50=1X@XY
M@_0!C/F*02,YMS #?G@T*\8?L%<0DXLK6S*FRFMAIJXB_*18@IB9Z<I^?WUZ
M$OSN^1(U=CAJ& #G^BM0XV_)GT J+H#6W)U??WMO-H<)&(%)+K NU!RT8WZ=
M 09W:]UT<K92AU(W(LA(X@69Z$Q.<'')'<P-*RC'B<M3@>!@,NBVU"+1)M$Z
M@G53VV@VG93 O1+X[W($__NRQ++^UX34^ ^@0W9,GJ[*+'$5TXW5PZ1/>(ZR
M#8^<XUKW ,T#@H'O,0^H7\ 5+ 0GJAF%)$7<<.=<\CR)FAS,P02-DHL$Q#>5
M8!L\ETJU?'<H<+1_%F"&8;R**D/QLN2<JA"P.<]*]DQU&OJ]\*MI,L:<-+Y;
MF-;.;JJ,U9+"^]=]FW 9E\'4DMIG4*L+6.MT[?!T@ /)(("4Z9YHU#]/:0;7
M/G-)F<A<?IOW+V#T@U#_.&*$)J+MQ.(-*E&#9 OVFG T]&FKNH<V*"@XEVRJ
M1)+9N9LP:E\7684RA L BS*@C_U@FPZ0^8K=B%D5*#PQ-:P:&E0"&N?@'LP2
M"T=S;!C%^6ZH5$J?%O@^ZGD(N6A"#87I)*U.W$4K35)A/ITH?)[Y/=))04@Z
MZT6=5T7P:7UE^^"W(2W$D5V?FO4NQ<;3NIX\.C4'9E&_3::, BV,6L@-J47W
MV-UA!Z%DE?I 5D$4^/F:5DO;4V58364*KQFY-O5S&)#&)K_8*#5X#?W.&@HM
M+9*5WD'2H-)<8IJ!RD6/SKELWGL6PX;?DN7D)ZUB65.\J*V#Y['HZ"ZQYT1D
MNJ_1BS!_="51@/!"@A%8)$RT<.$EW;MHOIA'"1: 7) ^Q*N"#>3<2J:2J]>>
M=T>3XQZ@<%I/[VE]PSZB>]]]1)^1L?WYYP;&]K0L/J2ETN.+-&T'*'TG@C5&
MH^GD+;J0!KS%HZ_.4Q*IA!'B$ .MS+8 _T$W:U=S@Q'F,Y2GI;AM$VEV1KWM
M7'JL-V'GSF[QTER"BM&(EH\,<NQ2QF.LH,9'77U$2JH@IC [-W!WQD.TH4O(
M-LBZ#Q\VRCHC8;A-$HNXUX4>T[D(?VJ:Q=E#Y)P;;+ $S4A\NE$FB.:T<[TM
MF$<NG5:CA]G,Z/8]37(ZB@.4,"0F@&XV<E!N[^'-9AL.[Y3+6#AV(<=VC>1K
MCK>1XD9=.3ZD<"OZI+QJ_$58;5J4T2#,W3$EA;"]*DH]*99V)91T I;M8CD+
MHS*EP:)NIL?H8M%.\?8)C4V'2V_<RF.>S]<=\V_T+JIG=#?3>_@"59_ZH<P7
M,ZWO"7EJET,)2S5"=\VR2OUVB[WKU)_V_HDSY<:ZFQ,%2O0^I)(DC*6],P[T
M]W'T.S[\/SHWZJ*,?_Q"[C1R84J0G[L6[.Z\XV8PDB"U!<[?/%]'!6!@7L*:
M;KTJB@\"[Q!TS@!F,)5'9O*(*^^S*!)@7?<@[MS^Z=@=;;OQ=?CHT?/N0MG!
MQ68F&>3&2,? [TV$=M#A7,[1<:@^K,0F9HZ2BLU;7S_O##"CF@3-A;: 4HIB
M':7@%F(5B;2"VMWYC3IH4_8?T\JQ9E+?8A6N"G\A+;=O:1Q+"@YOK(SP2NWD
M2SHEJ@ZEE"C0M[ XB M7&).:Y8X1 9AU)(5.7,C#)<LS?H.V)ME0N?)53WBQ
M6'O""0+MI]6M-Q]G*>7NT+GN[KQ7("L.T[IB%*3<&>ZTM"G$8^\/IYA/52?N
MR3KDX\Y*S?RB*#$W+XFY8LB7S#=R'UK95^U%X3>W#P]OKV\P9U.MR,2>+V=G
M2=U*4Z9 +?<*]9["!N38;0N>SHX!P_NJ"#$+\8.?#^_;)WW/%5=/CU,4/'83
M"K<M(;VOA3+:Y-].6&^#7O+O?V_B,W!#?^_1VX75A'Y&4=W7Z.T21$?([JJ^
MY7%;Z/SGW-F!:G>=NSM-2L1-J?DE]"UW=FRR!4_B8K4YYW!>L\Q((EC7"(1#
MA)GU9!G3PWUHB(0Q<73_[MXY@='VF3#[H<K$:ZS]V6L'O<#Z1H\K.GVE!IK_
MZ9HX D,[H])O2A8HM;>3/)Q$E^EL=@M]Q3GHR2CO\#[PHT$*>M0!FG'W\%[O
M4L)D-F0QU,R/;J0]4#2BN;(>!:S;<(.ARJ^Z=W]OM+]WM+^[TVO_J5D"MKB$
M--*T!S F:+C*_<?Q+0ZGLZO7IW"BXMOUJ=W_[E.[R?JXFKN."3!L;NJ9P/PL
M7#L4ZR'?!F9=EIL</10#\^E?TOUA3X!DNE<6:Y.)?50C)NFH-LZ;F#IY7:#T
M$]ANO;>4.X1:(=Y%=M-S5A/G.A'@9=I&G%KCIG"=/YW6J0%ES1F@FJMQ<<8!
M<:O3EAS]LPGMBD2JK=80CQLYI^&%#3CZ9'_OOO)X#F98T^?KZXRHU)OF;Y%#
M&U*9ASI;5YX?YIU=I 8:\%TJ95@$9RT=,Y9YE8+5K&@I@7-UDW<TE'[5><)M
M2R:HZ4S((O,OE/HU,&09%%49N;1822H!E: 74VE[*HT"$5<)\;Q0M)GI7>]N
M?M)1W#WHNXF]-_3W)R\X=]EK@,VDS,<__OXD%+^X?-_$A/SN$NY-J?N"V06Z
M/P^_.I'N]?>5:#"L=RK)7Y#*6+5;>1-C0D Z<0H3?E3@26I[@#?CS &]L69R
M&UL%T,;>O7/XM%<ABLT\<%8O2<F*7L!91'_@8T#_9E+-5DU>7>&WWKG3^Z9'
MK8 MO16+)N$S=-0F,T5*\173Q- R01$K/HHWUQ>+&@RH-6V?S6O;FVJUNH!I
M'B'7C*.C.]1OX>@NOOOHWMYDO\MY1.R>&ITZS<P:1@WTH2DFX5=HI!$4DR0P
M$"-;24V3_X$UNS;RJK+#R=F=FH3E!GE684'X(O--[1HS)7ZT@2H:';Q0UP>.
M>)$5RXKRXX1![[OV]$WVBU?L7T7Y(3I!A[B3YD>'#P\/H^.#WP[BQB-(_;&Z
M URZS@14[!PF@2Q7$W_#@PC\R0H\\V\\?6?]=XD03)(P(0$I]CEHWV=4\ON,
M"92ZUIH88 .$1D9_C&F8A?"-:H;]0*M-T%5S@4Z(IGNXKE"DSPS4CFU[(>8Z
M>MD#0N!\Z[1Q8_I< :AZ@)G+NIUTO=<;U>$/".Q:DPTVPW)02EYQM=F,2<9#
M.L>0JUGW:V@J$]'>L8.$%KP\JOM?J.,,5WP#B_$$J3,7;*^G\OH)-=)K\AMW
M@&_Y*EA(S%$Z*R[W8TY9(N6AAVGMA5OGYB;%]@C.(0)#)TM>N %\;O^J[.&X
M8L !OG?L/R9-73H8]*Y<W"'HJO&]E'%'<+G(*]1#A&*NK.I U$@U;(_ZFC@$
M-]C G%*ZBJDJR%&G?AP((UN1;(:U,FJTDD[)K"6K>KY'(8T0N]=]B0U_\.7L
MDOKI]AIG5(<(1)%7-18JEH.E?G+ PZ/75*IO&)!V<,-Y3\&P@%-/P/$&>E7^
M]Y2K7E!*GL4>K)/BJ-Q0F_[)!J\<+>:'L;-SLU;(E9U26V-^Y=D":B5NWDHY
MWZS#ZJ?O#JN;=%C=5 #5YT(+*:([QO%)\:Z+W[I'RHU2[,I7>;SU, $ZT)I[
M5 01T6O9J1&XOMGHQCO6<YNFQ%8O,MA25V"-&CC#HBA,BM[T5.ZYO^.IU )L
M5O/-\Y@@Q14%//DU5]TW*FSNE!&9!:5E;P-;[@?';+DD"=^QV^G4HWA24G[:
M]0-O!L>JY&'H7Y Q)]B<!P7?I9S*'N^J)&^#J$NQ3*<L<A#\\R2;[9,NRUB+
M:^B=8ZS4B=*1O 45H=^'K-RM=\V \"/6$*GDLG&E IP+? &C8[;E0__=;P'Z
MBN-U,_UVKJ4K!\/-W^5TIQ/;@$R2N$35,VX&]2I,^]YF=VYWQS1":3[?*33#
MY;"I.4XS#UU&(%YD'9B<;YU44WGK.<4@C7O $B>,D1;B>)D&9<+J7,;B:.72
MZ5UNHP"L$%1IM:RTCQ6Y%91TR,A?;W2QY_Y"T$J*UE@F/>PMIE7,N2E/J,RL
M_"-7R-^13\A=Y=( M3[78]O035?OQ%33#EVCTK+?'_6@)\$)=SH+MUIZ41G
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M*CBYJ4RJ#TP)>#*6AEVFLPN"?:W/*RP/A0/,'2))[=* I*TCD'59M[/E.2A
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MH^ K;Z\M;[EF29A?/@U_"0S)(2JJ\FX]Y534^VGWS^<;=5Q M+?'V+G#M_?
M)[ PH\D@U)2PZ"T(S$K6FZU61I+(&^Z,O5\^.U4WA]K'7FTMJ@ZPO1']WZ6%
MB!X!L@#DGB%-VFG8\7& SX9&!:_(NX/T$S;U&FT46>15>+]C\3V_D$*@7P1X
MS;5/C/+E?,0V:W-_A,@$[ZA)NX*B$P#)38J4O2;8[!%^>N^_]& M\74*HFDQ
MFQ%$-3_>4T3C6J6,LT6FQ<XTLZ!*'*38>*DDS=(<+PY+W*A?X"*3WLB*L:?
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MBZ"-5^5E$RD/S:G3AT/GCH 96Y!,/AB0Z.3%&ZLL<SJ>X5K18*9%-1%7/N9
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M+(B Z'"1*F()'R8E0:XN:ZJ7Q1?"$ RFBNZG..QBU&X25.)6IF<$R[JY@=#
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M2<6M>[;G2G2OP%D/3#<P8%[I+>@PN1@%"_>T[V"CUKD*-5+/6[HUVKBG*]4
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M)"J^'R^P5* WH27V "]BEW%7.Y_4XE'G'=)O,ZG&[:084>=B[6LU6A (X1Y
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MHY/GKUZ=OCT^>?GZE[_]</@#_?WV^-DS_5O.]BX>[=,W[YX]?T<?RZSXDUM
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M8,WN8(C$/I3K6U "N\\$V-JR][,3_*SE80DIJ=(%T01;)*8IQ5$386MBB["
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M%!FSV\N]&[D6<[V29&C3' XU]>R ,\.R 3&'V )O9>^O%#]I/:X[@&*G"<4
MS-,]XH7X&R7E[H?<^N>5&]'7/M3!RC/-8$?.IQ@544DF(,=!B]9IEKPZ)0)U
MO1L9/?AW/H.L@.7@#2+=@48 @/ARZ3AZ-!@/!X^&YCW:5."JC6E9+*C.@1\*
M_KXQ$K#/*E2%7UC3H2KZU(=R)JP5-/1'1N94M88]]6C\X)%1SY3)7^N6)PW[
MU?M2_)$BM!0[>++_WW15@0+S6T'U:@R-)O?*;SJFV>Q3\^U1*>EDM$'Z11H$
MK[*!F@4CB.A$57W26]\N<33"OT=Q\4*6R2R"\2G\7"Y^])$<NW*7JESP^F;5
MUJ3:E$GUYLZ;5%<)P/A9*B<#)?#BK/P,014QW>799::)C_QK!I)4]7M1, 9A
M5M58#E\2V,PX_5:4L2FQ$FA+^8TA+J6@ J$R6)B;<S'D:@T+2NE )UTX=+2D
MJEP+Q 'OC@BS#JXW3?FF9(2[[N#X8Y,=O&GKC&SZY+R]@R>'T,6X$!(VSVI"
M28-D0\XU=[K*F4N2X>J< FH9@Z':J]]\E\?L^TJP%SF\-4Y&\&*#]X*%PVEM
MH"9<#;A_W>1FWU7>*"&PNV/-*9V_U+W(!HB \)D;Y M][>(4_>WE%^M&[,K'
MDF066"$VJL@ 6#&Q8?#KET-C=R!0HXV%242H-VYC#-H!;3 N\N2]E@Q[XDCA
MRD!2V B=Z1!23UA(L"4F\N4(S]0!RPE?8L$?6J$MVEBFG1VN;]DG8/Q>.;#8
MG#'^,)EF67F_2<SO&Q% :8:%DN',['+RAV[3 1L6Z"=W4*"S*V>[1*Y22=Y$
MB-7B6.HML#=PK&2SBBZ9#I0%%G-@??Y4Q'>[1; TW?D5LG^HT?J'V+8=8+$C
MB"P=<.UP1Q+P5XJE,7&P^"W5O0OR55LS9].GXE]W\52X;$UI<C@=)\.W[9?7
M3L50(;&BY:#X%RGU[O2<EUUPG6Z=\5 _!,!PA*2'&SJ--"2K-#\V\W00=09F
M@H8+Y"(#XE51(38K*G8>5,A!+B-Y0-<A3KL7P?:RCM?-%CY7$9JM=MOL.?[M
M#I[C 58SZLRK[\Q?VO"C+Q^: ^>1*E$@#GWV?,J;V7KJ^#JL*@2K&\U!3GDL
M\K16 ,ZL)A^,J*2#E&7%C9C6O$1H3-:E:8ZA?43!I2-AZIQ<AR?_[+E(H<_D
M@?$!DR")JG,0:Z:KM3 H9GE2V\XJ^1N,+N4<-B)5$3%%])T4Y3D[1MR*6R;H
M#3'!E *)[ZCD[%#;)!5D'H/&-.J(15.^W'Q1_0J9GB'TK:2R9VZRE(WHNI[F
MVYQ*IPS\?1'VZX8^A4#(:2V-P,(^SI*H)!=KS$P[J4%M*VI!M177J*T0<,#;
M'-PV!_?3Y.",\8+5.'!,JPF=;L+^:YS>'F>E5^)T")3+,A4;[S3K#.TT.(.X
MM\(+KMM28L^0,]W%1ZJ[^'@8LEP:%U)T;V]/C#$I_7FL=:3CV.CF9A0DNMQ2
MS/R("^,C.IEET.,[C&L&@VC,"<6_)HL291S_^]))ZIX4!H1H2D=J+7#SZ1KW
MN)B">,!4-@-=: 9'(!!NTZN^1C1.6"P&L! %9B)P/5R5.$?G=-SSA@&Z5GE7
M^[@P98XW(39<UU$@K_T;#-B1LT(!O9[ 79\NM;-_Y4SCES7C>*G ?T8*#Y&2
MH1@%ET&;6C)!MR44 <(V$86=108OWFN>PMZIP#1/=>M;7IY&#JRO?1>=/DN7
M$%[>,N_?G0JB?5_G5$A&$G4DD(7Q4W0-\2ST-PKE'E9QHU-,8FNF"X,J"9A%
MIO,8;U+DH.R]@F"X95%@$&G7DP7!O1 %@LFVKBP(KBX*_J)S;FJ3>5N;B*OK
MW]G=N5(#3T_;3G#EKIU-'I^7ZQT?F^7Z08I5UU"OFP[KV/ ZB1F9CZ1XPFLT
MD9[P(UT95E_-\]637QXI '5!8M?4C9=P'<OTS:U*1"XUWY1UM&&)V)_57+=;
MHBT!M4SC3U683"U+Y2*JFB'GOJJ;X+*BF[[2F#4+8A"HJ:LB9G/"Y>2RG;AY
M\YN%UU^QPZZM8J^QP1J[RR4;;<1K4[E1MU2]J=$?D._<6P4*O#%H3SD@'#R>
M&,]; ]AXW.($!D;4]?-YD>:Z!(<.LX-U\-&_5".^Q= U*P:.M2VF4<PS%I]3
M>&!Y0X^3& YBXH'%>3T:;B.DS<Q8!W.WQV7LJ,4[@PX_+\K\WR@:>J4YO540
M:=FNEL&$P14% ;%RSH)W#PB^R0+KB:B\G''I>+\SJH6"-NS9DR\0CM3>(N0<
M2-K-EELA"(@FV>S^8H[S)7D.JZA&*;OF-ODF^K<HB602+X?_0$))$JC<+D T
M49T8VBW<KA\J^9J+UX0'U*C -%P/ZYK0FS%68%/\7+2&Q7A)[@KW%4.04#&#
MXV&QGW=WO(=BS7],7AJ5*+*FL?B[/KIO&VSQ4EAE&[MI[C^4AZ!W6?^G)89F
M.&83$K(H&">D"BS#8>@9</C0Z#OS\6"_BFV\),X? 315K**$S.A[WZ*"5JX!
MC"7#KM'I>6>P68!)M<<5GQ<"QFYJ]6)PF['3X9-%1 V.8'F"$PDGT3O)ISK^
M]-G8*XN2'7ID&NHQ AI3'W:.T#)=L:'AK3PJ.\((BKYR,7IC)\GKUQ 'H?0
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MT8AVM^D?YN*A^N>\_P-02P$"% ,4    " "OA351B5=A_F #   >#   $0
M            @ $     8VAW>2TR,#(P,#DQ-BYX<V102P$"% ,4    " "O
MA35186B??H,&  !*1P  %0              @ &/ P  8VAW>2TR,#(P,#DQ
M-E]L86(N>&UL4$L! A0#%     @ KX4U47</NG;&!   RBP  !4
M     ( !10H  &-H=WDM,C R,# Y,39?<')E+GAM;%!+ 0(4 Q0    ( *^%
M-5$Z%5A+@1$  &MK   -              "  3X/  !D-SDV,CAD.&LN:'1M
M4$L! A0#%     @ KX4U40TDPYA<DP  FRX#  \              ( !ZB
M &0W.38R.&1E>#$Q+FAT;5!+ 0(4 Q0    ( *^%-5&8U@H<0 \  -4[   /
M              "  7.T  !D-SDV,CAD97@U,2YH=&U02P4&      8 !@!Z
) 0  X,,

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
